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The enzyme 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS) 
catalyses the first step in the shikimate pathway, the condensation reaction 
between phosphoenolpyruvate (PEP) and erythrose 4-phosphate (E4P); leading to 
production of the aromatic amino acids tryptophan (Trp), phenylalanine (Phe) and 
tyrosine (Tyr). DAH7PS enzymes are classified into two homologous families, 
type I and type II, differentiated by molecular weight and amino acid sequence. 
The type I DAH7PS enzymes are further sub-divided into type Iα and type Iβ, 
based on amino acid sequence. DAH7PS enzymes share a common TIM barrel 
fold, which comprises the key catalytic residues required for DAH7PS activity. 
The presence of recruited structural elements to the core TIM barrel fold, confers 
allosteric regulation to the DAH7PS enzymes.    
The aim of this thesis is to explore the role of linker dynamics in allosteric 
regulation of the type Iβ DAH7PS enzyme, from the bacterium Thermotoga 
maritima. The hypothesis that the inter-domain linker determines molecular 
motion of the regulatory domains and consequently is responsible for allosteric 
regulation of the enzyme will be investigated.  
Chapter two describes the functional and structural characterisation of T. maritima 
DAH7PS (TmaDAH7PS) and three TmaDAH7PS linker variants, each involving 
a single amino acid substitution within the linker sequence. The response of the 
TmaDAH7PS linker variants to inhibitors will be investigated and compared to 
the wild-type TmaDAH7PS enzyme (
WT
TmaDAH7PS).   
Chapter three considers the role of the inter-domain linker in molecular motion of 
the enzyme, linking protein dynamics to the allosteric regulation mechanism 
employed by TmaDAH7PS. The studies presented in this chapter focus on the 
V65P
TmaDAH7PS linker variant, where a valine (Val) at position 65 has been 
substituted for proline (Pro). Comparisons to 
WT
TmaDAH7PS are drawn.   
iv 
 
Chapter four combines the results of chapters two and three to present a more 
comprehensive discussion of the role of linker dynamics in the allosteric 
regulation mechanism employed by TmaDAH7PS.  
Chapter five provides a summary of the work presented in this thesis, considering 
future work that would further understanding of the role of linker dynamics in 
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1.1 The Shikimate Pathway 
Proteins are essential biomolecules that control the chemistry of life. Organisms 
are able to generate the amino acids necessary for protein synthesis, via the 
reaction chemistry available to them. Animals are less adept at amino acid 
biosynthesis, in comparison to other eukaryotes or micro-organisms.
1
 The 
aromatic amino acids tryptophan (Trp), phenylalanine (Phe) and tyrosine (Tyr) are 
among those amino acids unable to be biosynthesised by animals. In micro-
organisms, plants, a few eukaryotes and discovered more recently, apicomplexan 
parasites, these important amino acids are produced by the shikimate pathway.
1-2
  
The shikimate pathway acts to convert phosphoenolpyruvate (PEP) and erythrose 
4-phosphate (E4P) to chorismate, via seven enzyme catalysed reactions (Figure 
1.1).
3-4
 Chorismate represents an important branch point in the pathway and is the 
precursor to the aromatic amino acids Trp, Phe and Tyr, as well as other aromatic 
metabolites; including folates, salicyclates and quinones.
5-6
 As chorismate is a 
point of divergence for the pathway, this step is carefully regulated, allowing the 
formation of products to be precisely controlled.
7-8
 Trp biosynthesis is achieved 
through conversion of chorismate to anthranilate in one branch of the pathway, 
while a second branch results in formation of both Phe and Tyr, via the precursor 
prephenate.
6-9
 The location of prephenate in the reaction pathway represents 






Figure 1.1: The seven enzyme catalysed reactions of the shikimate pathway, which lead to 
formation of chorismate, the precursor to the aromatic amino acids Trp, Phe and Tyr. Coloured in 
blue is the reaction catalysed by DAH7PS.   
3 
 
Animals have no equivalent reaction pathway and therefore the aromatic amino 
acids must be obtained through diet. The absence of the shikimate pathway from 
animal metabolism as well as multiple regulatory steps, present the shikimate 
enzymes as good targets for antimicrobial and herbicidal agents.
11
 5-enolpyruvyl 
shikimate 3-phospahte synthase (EPSPS), the sixth enzyme of the shikimate 
pathway, has already been shown to be inhibited by N-(phosphonomethyl)glycine, 
the active ingredient of the broad-spectrum herbicide glyphosate.
12-13
 The success 
of glyphosate has prompted further investigation of the shikimate enzymes and 





1.2 3-Deoxy-D-arabino-heptulosonate 7-phosphate Synthase 
The first step of the shikimate pathway is catalysed by the enzyme 3-deoxy-D-
arabino-heptulosonate 7-phosphate synthase (DAH7PS, EC 2.5.1.54).
14-15
 
DAH7PS enzymes catalyse the reaction between PEP and E4P to form 3-deoxy-
D-arabino-heptulosonate 7-phosphate (DAH7P), with the release of inorganic 
phosphate (Pi), via an aldol like condensation mechanism (Figure 1.1). As the first 
enzyme of the shikimate pathway, DAH7PS represents a major control point for 
metabolism of the pathways aromatic products. The DAH7PS enzymes are often 
feedback regulated by the end products of the shikimate pathway, controlling 
DAH7PS activity in response to cellular requirements.
14,16-17
 Multiple studies on 
DAH7PS enzymes from an array of organisms, has revealed numerous 
mechanisms exist to regulate DAH7PS activity.
18-19
 DAH7PS enzymes have 
evolved a number of different allosteric control mechanisms to establish feedback 
regulation and exhibit varied responses to the aromatic amino acids Trp, Phe and 







1.2.1 Catalytic Mechanism 
The reaction mechanism for the conversion of PEP and E4P to DAH7P by the 
enzyme DAH7PS was initially predicted to undergo a ping-pong mechanism.
21
 
Later kinetic studies, with increased purity of enzyme, confirmed that the kinetic 
mechanism is actually ordered sequential; where PEP binds to the enzyme first, 




DAH7PS catalysis is predicted to occur in three separate steps (Figure 1.2). The 
first step is thought to be initiated by nucleophilic attack of C3 of PEP, on C1 of 
E4P; which is activated for attack by coordination to a divalent metal ion.
23-24
 This 
step is stereospecific, and leads to formation of an oxocarbenium ion, which 
quickly reacts with water at the active site, to produce a bisphosphate hemiketal 
intermediate.
25
 The tetrahedral intermediate is subjected to C-O bond cleavage, 
releasing phosphate and forming acyclic DAH7P.
23
 Cyclisation of DAH7P is 
expected to occur after enzyme release, with greater than 99% adoption of the 





Figure 1.2: The proposed mechanism of PEP and E4P condensation to form DAH7P, catalysed by 
the enzyme DAH7PS.  
 
Mechanistic detail for DAH7PS catalysis has been elucidated through several key 




 PEP enabled the 
detection of stereospecific product formation by nuclear magnetic resonance 
(NMR) spectroscopy, confirming attack of the si face alkene functionality of PEP, 
to the re face aldehyde functionality of E4P.
25,29
 In addition 
18
O labelling exposed 
that the reaction proceeds via cleavage of the C-O bond of PEP, rather than the 
high energy O-P bond.
30
 In order for this to occur, water would need to be 
involved in nucleophilic attack at position C2 of PEP.
31
 Indeed incorporation of 
the 
18
O label in the DAH7P product was observed, corroborating the role of water 
in the catalytic mechanism of DAH7PS.  




1.2.2 Classification of DAH7PS Enzymes 
DAH7PS enzymes from different organisms have been classified into two distinct 
homologous families; designated type I and type II, based on molecular weight 
and amino acid sequence.
32-33
 The type I enzymes are smaller in size, typically 
only 30-40 kDa, while the type II enzymes often have a molecular weight greater 
than 50 kDa. The sequence similarity between the two families is less than 10%.
34
 
The type I enzymes are further subdivided into type Iα and type Iβ, differentiated 
by amino acid sequence. There is approximately only 20% sequence identity 
between each subtype.
35
 The type I DAH7PS enzymes are nearly always 
expressed in microbial organisms. However, the type II DAH7PS enzymes are 
expressed in both higher microbes and plants.
36-37
 
The elucidation of a number of DAH7PS enzyme structures, suggests that the 
DAH7PS enzymes have actually been classified based on structural additions to 
the core TIM barrel fold.
38
 The (βα)8 TIM barrel is the most commonly adopted 
protein fold and was first identified in triosephosphate isomerase.
39-40
 The protein 
fold is common to many enzymes involved in aromatic amino acid metabolism 
and has been identified in the tertiary structure of all DAH7PS enzymes.
39-40
 
It is hypothesised that many of the DAH7PS enzymes have arisen from gene 
duplication and gene fusion processes, due to the similarities between the 
DAH7PS types.
39
 The conserved monomeric TIM barrel fold, binding sites for 
substrate PEP, and positioning of key active site residues, indicate a common 
ancestry between the DAH7PS types.
41
 Differences between the DAH7PS 
enzymes involve extensions from the catalytic (βα)8 TIM barrel and oligomeric 
protein states, features both linked to regulatory function.
41
 It is likely that 








1.2.3 Structure of DAH7PS Enzymes 
The structure of DAH7PS enzymes from each classification is presented, 
beginning with the smaller, type Iβ DAH7PS enzymes and progressing to the 
larger, type II DAH7PS enzymes.  
Type Iβ DAH7PS Enzymes 
The thermophilic archaea Pyrococcus furiosus expresses a single, unregulated 
type Iβ DAH7PS enzyme (PfuDAH7PS) (Figure 1.3, left).
42
 DAH7PS enzymes 
adopt varied quaternary structures dependent on the organism in which they are 
expressed. PfuDAH7PS crystallises as a homotetramer, comprising two distinct 
interfaces (Figure 1.3, right).
43
 
The structure of PfuDAH7PS reveals the basic architecture, which all DAH7PS 
enzymes build upon, the (βα)8 TIM barrel.
43-44
 The TIM barrel fold consists of 
eight α-helices and eight parallel β-strands. As is typical for enzymes with this 
structure, the active site for DAH7PS enzymes is located at the C-terminal end of 
the (βα)8 TIM barrel.
40
 Active site geometry is facilitated by the extended β-α 
loops at the C-terminal, which provide the active site residues required for 
DAH7PS catalysis.
43
 The absence of an extension to the core TIM barrel of 
PfuDAH7PS, results in the enzyme being unregulated. No inhibition in the 
presence of any of the downstream products of the shikimate pathway has been 






Figure 1.3: Monomeric (left) and tetrameric (right) structures of PfuDAH7PS (PDB code 1ZCO), 
with the (βα)8 TIM barrel fold coloured in grey and the N-terminal extension coloured in blue. The 
tetrameric structure has been rotated about its diagonal axis, highlighting the protein interfaces.  
 
The thermophilic bacterium Thermotoga maritima also expresses a single, type Iβ 
DAH7PS enzyme (TmaDAH7PS). However, unlike PfuDAH7PS, the (βα)8 TIM 
barrel of TmaDAH7PS is adorned with a N-terminal regulatory domain. Each of 
the four monomeric units of TmaDAH7PS comprises a core TIM barrel fold; 
connected by a flexible linker region to a N-terminal regulatory domain, which 





Figure 1.4: Monomeric structures of TmaDAH7PS (PDB code 1RZM) (left) and LmoDAH7PS 
(PDB code 3NVT) (right), with the (βα)8 TIM barrel fold coloured in grey and the N-terminal 
extension coloured in blue. 
 
The ACT domain was named for the first three proteins it was discovered in: 
aspartate kinase, chorismate mutase and prephenate dehydrogenase, or tyrosine A; 
and functions as a ligand binding site for regulatory control of metabolic 
pathways, where the ligand bound is often the end product of the reaction 
series.
46-47
 Pervasiveness of the ACT domain in nature, suggests an early 
evolutionary recruitment for allosteric regulation of metabolic pathways.
46-47
 
The crystal structure of TmaDAH7PS is also homotetrameric. The four regulatory 
domains of TmaDAH7PS form the allosteric sites for the enzyme and function in 
a unique mechanism of allosteric regulation.
48
 TmaDAH7PS activity is regulated 
predominantly by the amino acid Tyr. In the absence of Tyr, the regulatory 
domains orient away from one another (open conformation), enabling substrates 
to access the active site however, when Tyr is bound a dramatic reorganisation of 
the regulatory domains occurs (closed conformation) (Figure 1.5).
48
    
10 
 
Figure 1.5: Tetrameric structures of TmaDAH7PS in the open (above) and closed conformation 
(PDB code 3PG9) (below) oriented to enable the N-terminal regulatory domains to be viewed. For 
each structure the (βα)8 TIM barrel fold is coloured grey and the N-terminal extension coloured in 
blue. 
 
In the presence of Tyr the N-terminal regulatory domains undergo a large rotation, 
with diagonally opposite regulatory domains moving toward the central axis of 
the tetramer.
48
 In their altered position the regulatory domains form new contacts 
with one another and the catalytic (βα)8 TIM barrel core.
48
 The inhibitor bound 
conformation places the regulatory domains directly above the TIM barrel fold, 
decreasing the ability of any substrate to reach the active site and greatly reducing 
catalytic activity of the enzyme.  
11 
 
DAH7PS from the bacterium Listeria monocytogenes (LmoDAH7PS) represents 
another type Iβ DAH7PS enzyme but is regulated by chorismate and prephenate, 
the substrate and product of the reaction catalysed by chorismate mutase.
49-50
 The 
catalytic domain of LmoDAH7PS adopts the common TIM barrel fold. However, 
an N-terminal extension with a high degree of sequence homology to the 
chorismate mutase enzyme is present (Figure 1.4, right). The chorismate mutase-




DAH7PS enzymes of this form can also be regulated by chorismate and 
prephenate via a C-terminal, instead of an N-terminal extension. The main 
difference between the protein architectures is the location of the regulatory 
domains and domain linkers.
9,50
 The inter-domain linker, which connects the 
regulatory domain to the core TIM barrel, enables the chorismate mutase-like 
domain to be positioned at either terminus of the TIM barrel and confer allosteric 
regulation to the enzyme. 
For type Iβ DAH7PS enzymes it is the interaction between diagonally opposite 
and not adjacent monomers of the tetramer that confers allosteric regulation.
34
 
This suggests that homomeric quaternary structure is essential for the allosteric 
regulation mechanisms employed by the type Iβ DAH7PS enzymes.
34
   
Type Iα DAH7PS Enzymes 
In contrast to the organisms that express type Iβ DAH7PS enzymes, organisms 
which encode type Iα DAH7PS enzymes often express multiple isozymes that are 
feedback regulated by Phe, Tyr or Trp. The Escherichia coli genome encodes 
three type Iα DAH7PS isozymes (EcoDAH7PS). Each isozyme exhibits specific 
sensitivity to a single aromatic amino acid.
51-52
 The Phe responsive EcoDAH7PS 
(EcoDAH7PS-Phe) is among the best characterised DAH7PS enzymes and was 





The overall structure of EcoDAH7PS-Phe is similar to the unregulated type Iβ 
DAH7PS enzymes. However, EcoDAH7PS-Phe has two modifications to the core 
(βα)8 TIM barrel. The first is a helical N-terminal extension and the second is a β-
hairpin fold, present at the catalytic core (Figure 1.6, left).
53
 The β-hairpin fold 




Figure 1.6: Monomeric structure of EcoDAH7PS-Phe (PDB code 1QR7) (left), SceDAH7PS 
(PDB code 1OFP) (centre) and NmeDAH7PS (PDB code 4HSN) (right), with the (βα)8 TIM barrel 
fold coloured in grey, the N-terminal extension coloured in pink and the β-hairpin fold coloured in 
yellow. 
 
The yeast Saccharomyces cerevisiae expresses two type Iα DAH7PS isozymes 
(SceDAH7PS), one inhibited by Phe and the other by Tyr.
24,39
 The presence of 
only two isozymes for S. cerevisiae is likely due to the fact that both isozymes can 
be inhibited by Trp, in addition to either Phe or Tyr.
54
 Both SceDAH7PS 
isozymes have extended (βα)8 TIM barrels, with a similar architecture to 
EcoDAH7PS-Phe (Figure 1.6, centre).
24
 For both EcoDAH7PS-Phe and 
SceDAH7PS the N-terminal domain from one monomer interacts with the N-






Figure 1.7: Tetrameric structure of EcoDAH7PS-Phe (above) and SceDAH7PS (below). For each 
monomeric unit the (βα)8 TIM barrel fold is coloured in grey, the N-terminal extension in pink and 
the β-hairpin fold in yellow. 
 
The Neisseria meningitidis genome encodes a single DAH7PS enzyme 
(NmeDAH7PS), which is inhibited by all three aromatic amino acids but shows 
the greatest level of inhibition in response to Phe.
38,55
 This is in direct contrast to 
the other type Iα DAH7PS enzymes, which are primarily sensitive to only a single 
amino acid. The structure of NmeDAH7PS also shows many similarities to 
EcoDAH7PS-Phe; crystallising as a homotetramer, with monomer subunits 




Type II DAH7PS Enzymes 
The best studied bacterial type II DAH7PS enzyme is the DAH7PS enzyme 
expressed by Mycobacterium tuberculosis (MtuDAH7PS). MtuDAH7PS is 
composed of four (βα)8 TIM barrels with N-terminal extensions that associate to 
form a homotetramer.
41
 The catalytic core of MtuDAH7PS is relatively similar in 
structure to that of the type I DAH7PS enzymes and has a comparable active site. 




Figure 1.8: Monomeric structure of MtuDAH7PS (PDB code 2B7O), with the TIM barrel fold 
coloured in grey, the N-terminal extension coloured in pink and the extended β2-α2 loop coloured 
in cyan. 
 
Two distinct Phe and one Trp binding site, which are related synergistically, have 
been identified for MtuDAH7PS.
56
 Trp binding occurs at site one, positioned at 
the tetramer interface, while Phe binds at site two, located at the dimer 
interface.
11,56
 Site three is close to the dimer interface and is also found to bind 
Phe. However, Tyr is bound preferentially. In the presence of Phe, Tyr binding 






The sites required to elicit the inhibitory response for MtuDAH7PS are sites one 
and two, verified by mutagenesis studies on site three, which concluded site three 
was not necessary for inhibition by Trp and Phe but enabled additional response 
to Tyr.
11,56
 The Phe and Trp binding sites communicate occupancy with one 
another and the active site.
56
 The allosteric response is precisely controlled by the 
number of sites that are occupied and the amino acids that occupy each site.
11
 A 
comparative analysis of the MtuDAH7PS ligand bound and ligand free structures 
indicates there is no average conformational change associated with ligand 
binding.
56-57
   
 
1.3 Enzyme Regulation 
Metabolism encompasses all chemical transformations that occur within the cells 
of living organisms.
58
 Metabolic pathways are formed by a series of 
interconnected biochemical reactions that are governed by enzymes. A metabolic 
pathway converts an initial metabolite to a specific biomolecule via a sequence of 
chemical reactions, each catalysed by an enzyme; where the product of the former 
enzyme becomes the substrate for the next, within the reaction series.
58-59
 The 
presence of regulatory enzymes at key junctions of the metabolic pathway, which 
are able to sense the metabolic requirements of the cell and adjust their catalytic 
activity in response, controls biomolecule formation.
59-60
   
Metabolic flux can be controlled at the level of the enzyme, through modulation 
of enzyme activity, or at the level of the gene, where transcriptional activity of the 
gene encoding the enzyme is regulated. This presents several mechanisms to 
control enzyme catalysis, including transcription of DNA into mRNA,
61
 
translation of mRNA into amino acids, post-translational protein modifications,
62
 
compartmentalisation and localisation of the enzyme,
63
 and feedback inhibition 
mechanisms, such as allostery.
64




1.3.1 Allosteric Regulation 
Allosteric regulation is crucial in the management of metabolic processes, signal 
transduction events and gene regulation.
65
 Allostery is defined by specific ligand 
binding that influences the function of a remote site of a protein. The distal ligand 
binding site is the allosteric site and the ligand that binds to the allosteric site is 
termed the allosteric effector.
66-67
 The allosteric response can be initiated through 
ligand binding, as is the case for DAH7PS enzymes but also through covalent 
modification or mutation at the allosteric site.
67-68
 The effect of binding an 
allosteric effector to the allosteric site, is transmitted through a protein, resulting 
in a change in protein function. Allosteric effectors can either increase or decrease 
protein function and are referred to as either allosteric activators or inhibitors 
respectively.
66-67
 Changes in protein function can include alterations in catalytic 
activity and/or ligand affinity (Figure 1.9).
66-67
 
Figure 1.9: Schematic representation of an allosterically regulated enzyme, shown in grey, where 
substrate affinity is altered upon allosteric effector binding. Binding of an allosteric activator to the 
allosteric site increases substrate affinity (above), while binding of an allosteric inhibitor to the 
allosteric site decreases substrate affinity (below).  
17 
 
History of Allosteric Regulation 
The concept of allostery was first established by Changeux, who identified that 
two distinct binding sites within a protein, assocciated with different ligands, 
could interact without proximity to one another.
66
 This led to the proposal of two 
models of allostery. The Monad-Wyman-Changeux  (MWC) model,
69
 where 
ligand binding shifts the equilibrium between two distinct conformational states, 
and the Koshland-Nemethy-Filmer (KNF) model,
70
 where proteins are considered 
to be flexible species, which undergo an induced-fit-like alteration in protein 
structure, in response to ligand binding.
66,71
 Both models can be used to describe 
allosteric regulation.   
In the past, allosteric regulation of protein function was considered to result from 
changes in protein structure, induced by ligand binding.
65,67
 Proteins that 
underwent large conformational changes in response to ligand binding were 
consequently used as model systems to describe allostery. Haemoglobin was one 
of the first proteins discovered to be regulated by an allosteric mechanism.
66-71
 
Composed of four subunits, haemoglobin undergoes detectable changes in 
conformation upon ligand binding.
67
 The clearly defined “T” (for tense) and “R” 
(for relaxed) states are easily identified and initial understanding of allostery came 
from observed differences in haemoglobin structure, resulting from allosteric 
effector binding.
66, 70
 As understanding of allostery progressed, it was realised that 
allostery is not limited to multimeric proteins that undergo changes in 
conformation but can also occur in monomeric proteins.
67
  
Following this, it was later realised that allosteric regulation can take place even 
in the absence of gross conformational change. It is now accepted that 
conformational change in response to ligand binding is only one mechanism of 
allosteric regulation and that allostery is also associated with changes in protein 
dynamics and conformational flexibility.
66
 Thus the molecular communication 
networks between the allosteric and active sites can be mediated by either 
18 
 
structural changes or alterations in relative protein flexibility, exemplifying the 




1.3.2 Regulation of DAH7PS Enzymes 
DAH7PS enzymes display a remarkable diversity of allosteric regulation 
mechanisms, which are necessary for precise control of metabolic flux. The 
evolution of allosteric control for DAH7PS enzymes is postulated to have 
occurred via domain recruitment, with the addition of a regulatory domain to the 
(βα)8 TIM barrel core.
16,48
 Initial studies on the unregulated DAH7PS enzymes 
helped to confirm that structural extensions to the (βα)8 TIM barrel are 
responsible for allosteric control of DAH7PS enzymes. It is possible that the 
unregulated DAH7PS enzymes are more primitive than their regulated 
counterparts and regulation is achieved at a different step of the pathway, or even 
at the level of transcription.
44
  
Type Iβ DAH7PS Enzymes 
Allosteric regulation of TmaDAH7PS is perhaps one of the best understood type 
Iβ DAH7PS regulation mechanisms that involve a conformational change upon 
ligand binding. TmaDAH7PS activity is regulated by Tyr and to a much lesser 
extent by Phe.
9,7,48 
In the absence of Tyr, the regulatory domains orient away from 
one another, enabling PEP and E4P to enter the active site. However, when Tyr is 
present the regulatory domains undergo a dramatic reorganisation; altering the 




A dynamic equilibrium between the active and inactive forms of TmaDAH7PS 
appears to exist, where the presence of Tyr alters the position of the equilibrium. 
In the absence of Tyr, the open conformation of TmaDAH7PS is favoured and the 
enzyme is active but upon Tyr binding the equilibrium is shifted, and the enzyme 
adopts a closed conformation that is inactive. If this is correct, Tyr is selectively 
19 
 
binding to a pre-existing but less populated sub-state of the protein ensemble; 




A large degree of structural similarity exists between the type Iβ DAH7PS 
enzymes LmoDAH7PS and TmaDAH7PS. Analysis of the structural features of 
each enzyme, led to the prediction that the mechanism of allosteric regulation for 
LmoDAH7PS, similar to TmaDAH7PS, might involve a conformational 
adjustment of the regulatory domains in response to inhibitor binding.
18,49
 The 
conformational change has been described for TmaDAH7PS but not yet for 
LmoDAH7PS. If the mechanism of allosteric regulation for the 
chorismate/prephenate regulated DAH7PS enzymes involves a comparable 
change in conformation to TmaDAH7PS, the similarity in structure and 
movement of the regulatory domains would indicate a conserved mechanism of 
allosteric regulation among the type Iβ DAH7PS enzymes; despite overall 
differences in the regulatory domains and inhibitor species.
9
    
LmoDAH7PS is allosterically regulated by chorismate and prephenate, upon 
ligand binding to the chorismate mutase-like regulatory domain.
9,49
 It is possible 
that the chorismate mutase-like regulatory domain, has arisen evolutionarily 
through gene duplication and gene fusion, to confer allosteric regulation.
49, 73
 
Gene duplication and gene fusion events would be an efficient use of genetic 
resources and are likely, considering other DAH7PS enzymes appear to have 
evolutionarily recruited their regulatory domains. This hypothesis is based on the 
observation that the chorismate mutase-like domain exhibits strong feedback 
inhibition by prephenate.
73
 It seems likely that an unregulated DAH7PS enzyme is 
the common ancestor of DAH7PS enzymes, and that allosteric regulation may be 
the evolutionary link between all DAH7PS enzymes.
73
  
Type Iα DAH7PS Enzymes 
The allosteric regulation mechanisms of the type Iα DAH7PS enzymes are more 
subtle than those of the type Iβ DAH7PS enzymes, which involve larger 
20 
 
conformational adjustments of discrete regulatory domains. In comparison, the 
type Iα DAH7PS enzyme regulation mechanisms involve much smaller 
conformational adjustments that lead to enzyme inhibition.  
It has been hypothesised that the type Iα DAH7PS isozyme EcoDAH7PS-Phe is 
allosterically regulated via a series of conformational changes, which propagate 
through the enzyme to the active site, upon binding of Phe. It was reported that 
the series of conformational changes alter positioning of the β2-α2 loop, which is 
required for substrate interaction.
74
 It is predicted that the orientation of PEP is 
altered in the inhibited conformation, preventing the necessary interactions 
required for catalytic activity. However, the altered positioning of PEP has only 
been observed in one study.
74
 SceDAH7PS has a very similar structure to 
EcoDAH7PS-Phe, with slight modifications which form an allosteric site for Tyr 
binding. As would be expected from their structures both enzymes employ a 
similar mechanism of allosteric regulation.
39
 
NmeDAH7PS is inhibited by all three aromatic amino acids. However, the 
sensitivity of the enzyme to Phe, Tyr and Trp differs. NmeDAH7PS shows the 
greatest level of inhibition in response to Phe but the response to Trp is 
significantly less than the other aromatic amino acids.
38
 There is no significant 
conformational change for NmeDAH7PS observed upon inhibitor binding, so the 
mechanism of allosteric regulation likely involves subtle changes in protein 
dynamics.
38
   
Type II DAH7PS Enzymes 
There is much interest in the regulatory mechanisms of the type II DAH7PS 
enzymes because of their potential as drug targets, in the pathogenic organisms in 
which they are expressed.
41
  M. tuberculosis is the causative agent of tuberculosis 
and gene disruption studies have revealed that the shikimate pathway is essential 






MtuDAH7PS reveals a complex allosteric regulation mechanism unlike that 
identified for any other DAH7PS enzyme.
75
 MtuDAH7PS activity is inhibited by 
a combination of Phe, Tyr and Trp, in a complex synergistic regulation 
mechanism.
9,11,56
 Interestingly the inhibitory effect of Phe, Tyr and Trp in 
combination, is much greater than that observed for any single inhibitor in 
isolation.  
Synergy is observed in particular between Phe and Trp, which exhibit the greatest 
level of inhibition compared to any other combination.
41,57
 Subsequent addition of 
Tyr to Phe and Trp, markedly increases the inhibitory response, with Tyr binding 
resulting in complete loss of catalytic activity.
11
 It is predicted that a synergistic 
DAH7PS may have evolved, to allow more precise control over regulation 
processes, in response to metabolic requirements.
11
 The synergistic response of 
MtuDAH7PS enables highly specific production of the shikimate amino acids.
57
   
The mechanism of allosteric regulation for MtuDAH7PS, likely involves an 
alteration in the dynamic properties of the protein; in response to synergistic 
binding of Phe and Trp.
56-57
 Analysis of temperature factors over the course of a 
molecular dynamics simulation suggests that binding of Phe and Trp, increases 
the flexibility of the β2-α2 loop. Increased flexibility of the β2-α2 loop is 
hypothesised to increase the entropy penalty of substrate binding, making it more 
difficult to bind substrate and leading to enzyme inhibition.
9,56
 The proposed 
mechanism of inhibition supports the theory that the β2-α2 loop is conserved 
across DAH7PS types because it plays an important role in allosteric regulation of 
DAH7PS enzymes.
9
   
The unusual approach to allosteric regulation demonstrated by MtuDAH7PS 
provides some insight into the different mechanisms of allostery that can evolve. 
The genome of M. tuberculosis codes for only a single DAH7PS enzyme, which 
may be the reason for the need to evolve a highly sensitive enzyme that is able to 
be regulated effectively, by multiple aromatic amino acids.
11
 Other enzymes 
known to display synergistic allostery, such as glutamine 
22 
 
phosphoribosylpyrophosphate amidotransferase from Bacillus subtilis, are also 
involved in the first step of the biosynthetic pathway in which they function.
11
 
Supporting the idea that synergistic allostery is employed when multiple end 
products are produced and regulation of metabolic control is particularly 
important. 
Summary of DAH7PS Enzyme Regulation     
DAH7PS enzymes display an immense variety of allosteric regulation 
mechanisms that are facilitated by the presence of discrete regulatory domains or 
smaller extensions to the core, catalytic (βα)8  TIM barrel. It has been proposed 
that the mechanism of allosteric regulation defines each of the DAH7PS enzyme 
types. This continues to be supported, as additional DAH7PS structures are 
reported and the enzymes regulatory mechanisms discovered.  
Comparison of the DAH7PS enzymes exposes many structural similarities. 
However, differences in features related to allosteric regulation are apparent. 
Small alterations to the allosteric binding pocket characterise the type Iα DAH7PS 
enzymes, while the position of discrete regulatory domains define the type Iβ 
DAH7PS enzymes.
9
 It seems likely that DAH7PS enzymes have evolved from a 
primitive, unregulated DAH7PS enzyme and that over the course of evolution, 
some members of the DAH7PS family have acquired extra domains for the 
purpose of feedback regulation. Regardless, the DAH7PS enzymes exhibit a wide 
range of allosteric regulation mechanisms, which incorporate both conformational 






1.4 Objectives of Thesis 
The overall aim of this research is to explore allosteric regulation of 
TmaDAH7PS, by investigating the role of the inter-domain linker in the enzymes 
mechanism of allostery. To date there has been no investigation into the flexibility 
of the TmaDAH7PS linker region, nor has the dynamic role the linker plays in the 
conformational change upon Tyr binding been studied. Tyr binding potentially 
perturbs linker dynamics, facilitating allosteric propagation.
76
 If this is the case, 
particular amino acids of the linker region may be conserved at set positions, to 
ensure transition through the propagation pathway upon Tyr binding.
76
 Thus 
mutation of key amino acids of the linker region, may affect protein function, due 
to either altered flexibility or disruption of the allosteric propagation pathway; 
enabling the function of the linker sequence to be examined.
76
  
The studies presented in this thesis investigate the following aims: 
 Kinetically and structurally characterise TmaDAH7PS and several variant 
TmaDAH7PS enzymes, to examine the role of the linker sequence in the 
mechanism of allosteric regulation by Tyr. 
 Explore protein dynamics of TmaDAH7PS and variant TmaDAH7PS 
enzymes, via molecular dynamics simulations, to determine if DAH7PS 
allosteric propagation pathways can be predicted in silico.  
 Discuss the results from the biochemical characterisation of TmaDAH7PS 
and the TmaDAH7PS linker variants, in combination with the in silico 
results, to unravel the dynamic nature of the allosteric regulation 













Biochemical Characterisation of Thermotoga maritima 
DAH7PS and Three Linker Variants 
 
2.1 Introduction 
Hyperthermophiles are organisms that thrive in temperatures exceeding 60 °C and 
have been discovered in geothermally heated environments, such as deep-sea 
hydro-thermal vents.
42
 Most hyperthermophiles belong to the domain archaea. 
However, bacteria classified in the order Thermotogales are also 
hyperthermophilic.
42,77
 T. maritima is a member of the order Thermotogales, and 
was first discovered in the geothermally heated sediment off the coast of Vulcano, 
Italy. T. maritima is able to grow at temperatures between 55-90 °C, although the 
optimal temperature for growth is 80 °C.
78
  
Hyperthermophiles are considered to be the earliest known ancestor of all extant 
life on Earth. Thermotogae have been the subject of numerous evolutionary 
studies, as the phylum is among the deepest branching bacterial species.
79-80
 The 
T. maritima genome encodes a single type Iβ DAH7PS enzyme, and it is 
anticipated that investigation of this enzyme, will provide insight into the 
divergence of the DAH7PS enzyme classes and their distinct mechanisms of 
regulation.  
The allosteric regulation mechanism of TmaDAH7PS involves gross 
conformational change, associated with Tyr binding. Conformational adjustment 
of the regulatory domains is facilitated by the flexible inter-domain linker, which 
comprises residues 64-80, and connects the catalytic TIM barrel to the N-terminal 
regulatory domain of each protein chain (Figure 2.1).  
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Figure 2.1: Monomeric structure of TmaDAH7PS, with the (βα)8 TIM barrel fold coloured in grey 
and the N-terminal extension coloured in blue. Highlighted is the inter-domain linker, with the 
residues arginine 64 (Arg64), valine 65 (Val65) and proline 68 (Pro68) labelled.  
 
To transition from the open to closed conformation of TmaDAH7PS, the inter-
domain linker must adopt altered conformations, in order to accommodate 
movement of the regulatory domains. Overlay of the open and closed monomeric 
structures of TmaDAH7PS, accentuates the altered conformation of the linker, for 
the open and closed enzyme forms (Figure 2.2).  
27 
 
                      
Figure 2.2: Monomer overlay of the open and closed conformations of TmaDAH7PS. The open, 
ligand free conformation, is coloured blue and the closed, Tyr bound conformation, is coloured 
red.   
 
The movement of the regulatory domains in response to ligand binding 
necessitates some part of the linker region to be flexible. The allosteric regulation 
mechanism also requires the allosteric signal to be transmitted from the site of 
ligand binding, to the active site of the protein. It is possible that the amino acids 
of the linker sequence, encode an allosteric propagation pathway that enables the 
allosteric signal to be communicated to the active site for TmaDAH7PS.
81
   
Characterisation of TmaDAH7PS has been reported previously
82
 but is presented 
here, in combination with three new linker variants, to enable direct structural and 
functional comparisons to be made. This chapter describes the expression, 
purification and biochemical characterisation of wild-type TmaDAH7PS; herein 
described as 
WT





2.2 Selection of TmaDAH7PS Linker Variants 
With consideration to the inherent flexibility the linker must have, along with the 
possibility of a pre-encoded allosteric propagation pathway, the individual amino 
acids of the linker sequence were examined, to determine which amino acids are 
important for allosteric regulation of TmaDAH7PS. A sequence alignment was 
performed, to determine the amino acids of the linker, required for linker 
functionality (Figure 2.3). The residues valine 65 (Val65), tyrosine 69 (Tyr69), 
lysine 70 (Lys70) and serine 73 (Ser73) exhibited a high level of conservation 
among the type Iβ DAH7PS enzymes.  
Figure 2.3: Clustal Ω sequence alignment of the type Iβ DAH7PS sequences. Of the full sequence 
alignment, only the residues of the linker, for the first ten type Iβ DAH7PS sequences are shown.   
 
Linker variants were selected, to explore the effects of both decreased and 
increased linker flexibility. The first linker variant, substituted Val at position 65, 





TmaDAH7PS was selected for two key reasons; first, 
because the high conservation score indicates that Val65 is conserved for 
functionality, amongst DAH7PS enzymes; second, a comparison of the ligand free 
and ligand bound crystal structures for TmaDAH7PS, demonstrated a large 
variation in the phi (φ) and psi (ψ) angles, of Val65. The difference in φ and ψ 
angles for Val65, was first reported by Cross
82
 but has been investigated more 
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thoroughly here, and is presented in chapter three, within the targeted molecular 
dynamics section.   
Following preliminary studies on 
V65P
TmaDAH7PS, two additional linker variants 
were selected. The second linker variant substitutes Arg64 for Pro 
(
R64P
TmaDAH7PS), and was selected for similar reasons to 
V65P
TmaDAH7PS. 
Unlike position 65 however, position 64 is oriented away from the site of Tyr 
binding. The third linker variant substitutes Pro68 for alanine (Ala) 
(
P68A
TmaDAH7PS), and was chosen to increase flexibility of the inter-domain 
linker. Pro68 is positioned at the centre of the most flexible region of the linker 
but is itself, a very inflexible amino acid, so could play an important role in linker 
dynamics.   
 
2.3 Cloning, Expression and Purification  
 
2.3.1 Cloning of 
WT
TmaDAH7PS 
Prior to the beginning of this research, the gene for TmaDAH7PS (locus tag 
TM0343) had been amplified from T. maritima MSB8 (DSM 3109) genomic 
DNA and ligated into the pT7-7 vector.
83
 The pT7-7 vector was transferred into E. 
coli XL1-Blue cells and the resulting construct transformed into E. coli 
BL21*(DE3) cell lines for protein expression. Sequencing analysis confirmed the 
presence of the correct sequence, within the expression plasmid.  
 
2.3.2 Expression and Purification of 
WT
TmaDAH7PS 
The pT7-7 vector is under control of the lac promoter, which is induced by 
lactose.
 WT
TmaDAH7PS expression was therefore induced by isopropyl-1-thiol-β-
D-galactopyranoside (IPTG), which is a synthetic analogue of lactose that initiates 
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transcription of the lac operon but is not metabolised by the cell, as lactose is. 
Upon harvesting, the cell pellet was lysed and centrifuged, with the soluble 
fraction found to exhibit DAH7PS activity.  
WT
TmaDAH7PS was purified from the crude lysate, using a purification procedure 
previously developed by Cross et al.
48, 82
 As T. maritima is a hyperthermophile, 
the first step of the purification involved heat treatment of the cell lysate. When 
the cell lysate was heated to elevated temperatures, E. coli proteins present within 
the sample were precipitated out of solution, purifying 
WT
TmaDAH7PS. In a 
slight modification to the procedure, heat debris was diluted with lysis buffer prior 
to centrifugation, improving collection of 
WT
TmaDAH7PS following the heat 
treatment. 
 (NH4)2SO4 (1 M) was added to the supernatant, which was loaded onto a 
Source
TM
 15PHE column, pre-equilibrated with 1 M (NH4)2SO4.  As the 
concentration of (NH4)2SO4 was lowered from 1 M to 0 M, in a step-wise fashion, 
WT
TmaDAH7PS was eluted from the column. Following hydrophobic interaction 
chromatography (HIC), 
WT
TmaDAH7PS was separated from remaining 
biomolecules, via size exclusion chromatography (SEC). HIC fractions 
corresponding to 
WT
TmaDAH7PS were pooled and concentrated, before loading 
to the Superdex 10/300 SEC column. Fractions corresponding to purified 
WT
TmaDAH7PS were pooled, concentrated and flash-frozen in liquid N2, before 
storage at -80 °C.  
Samples were taken at each stage of the purification procedure and analysed for 
increasing purity, by sodium dodecyl sulfate (SDS)-polyacrylamide gel 
electrophoresis (PAGE) (Figure 2.4). Two litres of cell growth resulted in 
approximately 8 mg of purified 
WT
TmaDAH7PS protein.  
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Figure 2.4: SDS-PAGE analysis of 
WT
TmaDAH7PS purification. Lane M: molecular weight 
marker; Lane 1: supernatant after heat treatment; Lane 2: sample loaded to HIC column; Lane 3: 
pooled HIC fractions; Lane 4-8: fractions collected post SEC.   
 
2.3.3 Site-directed Mutagenesis 
V65P
TmaDAH7PS was previously constructed by site-directed mutagenesis and 





TmaDAH7PS a QuikChange Lightning site-directed 
mutagenesis kit from Stratagene was utilised to introduce each mutation into the 
TmaDAH7PS pT7-7 plasmid, via extension of mutagenic primers.  
The PCR product for each mutagenesis reaction was digested by DpnI and 
transformed into Stellar cells for protein expression. Colonies were grown at 37 
°C overnight and the plasmids extracted for DNA sequencing. Sequencing results 





2.3.4 Expression and Purification of TmaDAH7PS Linker 
Variants 
The procedure outlined above for 
WT
TmaDAH7PS, was utilised for expression 







For each linker variant, samples were taken at each stage of the purification 







TmaDAH7PS is presented 
in Figures 2.5-2.7 respectively. Two litres of cell growth resulted in 
approximately 7.5 mg of purified 
V65P
TmaDAH7PS protein, 7 mg of 
R64PP
TmaDAH7PS and 7 mg of 
P68A
TmaDAH7PS. 
Figure 2.5: SDS-PAGE analysis of 
V65P
TmaDAH7PS purification. Lane M: molecular weight 
marker; Lane 1: crude lysate; Lane 2: supernatant after heat treatment; Lane 3: pooled HIC 
fractions; Lane 4: pooled SEC fractions. Lanes are loaded at 1 mg/mL.  
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Figure 2.6: SDS-PAGE analysis of 
R64P
TmaDAH7PS purification. Lane M: molecular weight 
marker; Lane 1: supernatant after heat treatment; Lane 2: pooled HIC fractions; Lane 3: sample 





Figure 2.7: SDS-PAGE analysis of 
P68A
TmaDAH7PS purification. Lane M: molecular weight 
marker; Lane 1: supernatant after heat treatment; Lane 2: pooled HIC fractions; Lane 3: pooled 
SEC fractions; Lane4: concentrated 
P68A





2.4 Molecular Weight Confirmation 
The molecular mass of each protein was determined by electrospray ionisation 
mass spectrometry and compared to the theoretical mass, calculated from the 
amino acid sequence, with the ExPASy – ProtParam tool. 
WT
TmaDAH7PS had a 
mass of 37,378.77 Da, which is nearly identical to the calculated mass of 






TmaDAH7PS were also nearly identical to the 
theoretical masses; 37,376.87 Da, 37,319.65 Da and 37,352.74 Da compared to 
37,376.15 Da, 37,319.09 Da and 37,352.13 Da respectively.   
 
2.5 Kinetic Characterisation  
A continuous spectrophotometric assay was performed at 60 °C for each enzyme, 
by measuring the disappearance of PEP absorbance at 232 nm. The assay was 
performed at 60 °C, rather than the optimal temperature of 80 °C for 
TmaDAH7PS activity,
78
 due to the decreased stability of  E4P at higher 
temperatures. The kinetic assay was initiated by the addition of E4P (300 µM) to 
the reaction mixture, which contained BTP buffer (50 mM BTP, pH 7.3), MnSO4 
(100 µM) PEP (200 µM) and enzyme.     
 





TmaDAH7PS, the apparent Km values for PEP and E4P were 17 ±0.70 and 










 (left) was determined by 
fixing the [E4P] at 300 μM and varying the [PEP] from 20 to 200 μM. The Km
E4P
 (right) was 
determined by fixing the [PEP] at 200 μM and varying the [E4P] from 20 to 300 μM. The assays 
were performed in triplicate and each data point is presented on the curve.  
 
2.5.2 Kinetic Parameters of TmaDAH7PS Linker Variants  
For 
V65P
TmaDAH7PS, the apparent Km values for PEP and E4P were 18 ±0.70 and 
35 ±1.5 respectively (Figure 2.9). The kcat was calculated to be 8.4 ±0.10 s
-1
.  




 (left) was determined by 
fixing the [E4P] at 300 μM and varying the [PEP] from 20 to 200 μM. The Km
E4P
 (right) was 
determined by fixing the [PEP] at 200 μM and varying the [E4P] from 20 to 300 μM. The assays 




TmaDAH7PS, the apparent Km values for PEP and E4P were 19 ±1.0 and 










 (left) was determined by 
fixing the [E4P] at 300 μM and varying the [PEP] from 20 to 200 μM. The Km
E4P
 (right) was 
determined by fixing the [PEP] at 200 μM and varying the [E4P] from 20 to 300 μM. The assays 




TmaDAH7PS, the apparent Km values for PEP and E4P were 18 ±1.0 and 








 (left) was determined by 
fixing the [E4P] at 300 μM and varying the [PEP] from 20 to 200 μM. The Km
E4P
 (right) was 
determined by fixing the [PEP] at 200 μM and varying the [E4P] from 20 to 300 μM. The assays 
were performed in triplicate and each data point is presented on the curve. 
 
The kinetic parameters for each of the TmaDAH7PS enzymes are presented in 








Table 2.1: Kinetic parameters for TmaDAH7PS enzymes 
 
Overall, the apparent Km values determined for 
WT
TmaDAH7PS and the 





 indicating the concentration of each substrate required to 





TmaDAH7PS have increased kcat 




2.6  Feedback Inhibition Studies 
The response of 
WT
TmaDAH7PS and the TmaDAH7PS linker variants to 
increasing concentrations of either Tyr or Phe was determined by varying the 
ligand concentration from 0 μM to 400 μM. The assay outlined above was 
employed, with [E4P] fixed at 300 μM and [PEP] at 200 μM.   
 





TmaDAH7PS is particularly sensitive to Tyr and was reduced to a 
constant 17.8% residual activity (Figure 2.12). This level of activity has been 
reported previously for 
WT






TmaDAH7PS is much less sensitive to Phe and even at the highest 
concentration measured, retains greater than 50% maximal activity.  
                             
Figure 2.12: Response of 
WT
TmaDAH7PS to increasing concentrations of Tyr (□) and Phe (◊). 
Each data point was measured in triplicate and the average value plotted.  
 
2.6.2 Inhibition of TmaDAH7PS Linker Variants 
V65P
TmaDAH7PS was less responsive to Tyr, compared to 
WT
TmaDAH7PS and 
requires much higher concentrations to achieve the reduced level of inhibition 
observed (Figure 2.13). 
V65P
TmaDAH7PS exhibits approximately 75% maximal 




TmaDAH7PS is also less sensitive to Phe.  
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Figure 2.13: Response of 
V65P
TmaDAH7PS to increasing concentrations of Tyr (□) and Phe (◊). 
Each data point was measured in triplicate and the average value plotted.  
 
R64P
TmaDAH7PS exhibits similar activity to 
WT
TmaDAH7PS in the presence of 
both Tyr and Phe (Figure 2.14). 
R64P
TmaDAH7PS is slightly less sensitive to both 
Tyr and Phe, reduced to approximately 30% maximal activity in the presence of 
the highest concentration of Tyr. 
                           
Figure 2.14: Response of 
R64P
TmaDAH7PS to increasing concentrations of Tyr (□) and Phe (◊). 
Each data point was measured in triplicate and the average value plotted.  
 
P68A
TmaDAH7PS was the most sensitive to Tyr, reduced to a residual activity less 
than 10% of the maximal rate (Figure 2.15). 
P68A
TmaDAH7PS exhibited the 
greatest difference in inhibition for each ligand, reduced to approximately 70% 
40 
 




TmaDAH7PS is more sensitive to inhibition by Tyr but less sensitive to 
inhibition by Phe.  
                                     
Figure 2.15: Response of 
P68A
TmaDAH7PS to increasing concentrations of Tyr (□) and Phe (◊). 
Each data point was measured in triplicate and the average value plotted.  
 
For clarity the response of the TmaDAH7PS enzymes to increasing concentrations 
of either Tyr (Figure 2.16) or Phe (Figure 2.17) is presented below.  
                               
Figure 2.16: Response of 
WT
TmaDAH7PS (◊), V65PTmaDAH7PS (□), R64PTmaDAH7PS (Δ) and 
P68A
TmaDAH7PS (x) to increasing concentrations of Tyr. Each data point was measured in 




                                    
Figure 2.17: Response of 
WT
TmaDAH7PS (◊), V65PTmaDAH7PS (□), R64PTmaDAH7PS (Δ) and 
P68A
TmaDAH7PS (x) to increasing concentrations of Phe. Each data point was measured in 
triplicate and the average value plotted. 
 
2.7 Differential Scanning Fluorimetry 
Differential scanning fluorimetry (DSF) enables the thermal stability of proteins 
to be assessed, by measuring the temperature at which a protein becomes 
disordered.
84
 DSF utilises a fluorescent dye that binds to the hydrophobic amino 
acids of a protein. Fluorescence is detected as the protein denatures and the 
hydrophobic amino acids become exposed, with increasing temperature.
84
 DSF 
was performed to investigate the thermal stability of 
WT
TmaDAH7PS and probe 
the impact of the linker mutations on thermal stability of the TmaDAH7PS linker 
variants.  
 





TmaDAH7PS, the melting temperature (Tm) was determined to be 93 °C in 
the absence of Tyr and 95 °C in the presence of Tyr (Figure 2.18). The melting 
temperatures are broadly in line with those previously reported for the first 






TmaDAH7PS was reported to denature 
in two steps, the first occurring around 96 °C and the second at 100 °C.
82
 The 
temperature range able to be accessed via DSF was not high enough to enable 
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detection of the second denaturation step for 
WT
TmaDAH7PS. Therefore, only 
relative comparisons for the first denaturation step were able to be made.  
                               
Figure 2.18: Thermal stability of 
WT
TmaDAH7PS and the TmaDAH7PS linker variants, in the 
absence (blue) and presence (red) of Tyr (1 mM). Each data point was measured in triplicate and 
the average value plotted.  
 
2.7.2 Thermal Stability of TmaDAH7PS Linker Variants 
The TmaDAH7PS linker variants all exhibited similar melting temperatures to 
WT
TmaDAH7PS, in both the absence and presence of Tyr (Figure 2.18). Similar 
melting temperatures suggest that the individual linker mutations have not 
significantly impacted the thermal stability of the TmaDAH7PS linker variants. 
Accurate determination of Tm by DSF, for the TmaDAH7PS enzymes, was limited 
by the temperature able to be achieved during the experiment. However, for 
investigating relative changes in thermal stability, the technique was suitable for 
preliminary analysis.    
 The Tm for each of the TmaDAH7PS enzymes, in the absence and presence of 





Table 2.2: Tm for TmaDAH7PS enzymes in the absence and presence of 1 mM Tyr  
 
 
2.8 Small Angle X-ray Scattering 
Small angle X-ray scattering (SAXS) was employed to assess the solution 
structure of 
WT
TmaDAH7PS and the TmaDAH7PS linker variants in the absence 
and presence of 1 mM Tyr. Each enzyme was analysed by SEC-SAXS, to collect 
scattering data from the monodisperse TmaDAH7PS species. Each enzyme was 
loaded to the column at a concentration of 10 mg/mL. Expression and purification 
of 
R64P
TmaDAH7PS occurred after the scheduled SAXS beamline time, so this 
data was unable to be analysed within the time frame of this thesis.  
   
2.8.1  Characterisation of 
WT
TmaDAH7PS by Small Angle X-ray 
Scattering 
Guinier analysis of the scattering profile for 
WT
TmaDAH7PS in the absence of 
Tyr produced a radius of gyration (Rg) of 34.2 ±0.1 Å. The pair-distribution 
function (P(r)) was determined by indirect Fourier transformation and calculated 
the Rg to be 33.8 ±0.1 Å, and the maximum scattering particle (Dmax) to be 131 Å. 
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Overlay of the SAXS data for 
WT
TmaDAH7PS in the absence and presence of 
Tyr, revealed a noticeable change in the scattering profiles (Figure 2.19). In the 
presence of Tyr a radius of gyration (Rg) of 33.0 ±0.1 Å was determined by 
Guinier analysis, while the P(r) function calculated a Rg of 32.5 ±0.1 Å. The Dmax 
was 103 Å and Vp was 215000 Å.
85
 The scattering data is consistent with a 
conformational change for 
WT
TmaDAH7PS in the presence of Tyr.   
Figure 2.19: Overlay of the SAXS scattering profiles for 
WT
TmaDAH7PS, in the absence (blue) 
and presence (red) of 1 mM Tyr.  
 
2.8.2  Characterisation of TmaDAH7PS Linker Variants by Small 
Angle X-ray Scattering 
Guinier analysis of the scattering profile for 
V65P
TmaDAH7PS in the absence of 
Tyr produced a radius of gyration (Rg) of 33.6 ±0.3 Å, while the Rg determined by 
the P(r) function was 33.1 ±0.1 Å.  The Dmax was 115 Å and the Vp was calculated 





Overlay of the SAXS data for 
V65P
TmaDAH7PS in the absence and presence of 
Tyr, revealed minor changes in the scattering profiles (Figure 2.20). In the 
presence of Tyr a radius of gyration (Rg) of 33.2 ±0.1 Å was determined by 
Guinier analysis, while the P(r) function calculated a Rg of 32.5 ±0.1 Å. The Dmax 
was 100 Å and Vp was 221000 Å.
85
 The scattering data for 
V65P
TmaDAH7PS 
suggests little conformational change in the presence of Tyr.  
      
Figure 2.20: Overlay of the SAXS scattering profiles for 
V65P
TmaDAH7PS, in the absence (blue) 
and presence (red) of 1 mM Tyr. 
 
Guinier analysis of the scattering profile for 
P68A
TmaDAH7PS in the absence of 
Tyr produced a radius of gyration (Rg) of 34.6 ±0.4 Å, while the Rg determined by 
the P(r) function was 34.2 ±0.1 Å.  The Dmax was 106 Å and the Vp was calculated 
to be 223000 Å.
85
  
Overlay of the SAXS data for 
P68A
TmaDAH7PS in the absence and presence of 
Tyr, revealed a large change in the scattering profiles (Figure 2.21). In the 
presence of Tyr a radius of gyration (Rg) of 32.8 ±0.2 Å was determined by 
Guinier analysis, while the P(r) function calculated a Rg of 32.2 ±0.1 Å. The Dmax 
was 99 Å and Vp was 219000 Å.
85
 The scattering data for 
P68A
TmaDAH7PS 
suggests a large conformational change in the presence of Tyr. The 
46 
 
conformational change observed is more significant than that observed for 
WT
TmaDAH7PS. 
Figure 2.21: Overlay of the SAXS scattering profiles for 
P68A
TmaDAH7PS, in the absence (blue) 
and presence (red) of 1 mM Tyr. 
 
2.8.3  CRYSOL Fitting of SAXS Profiles for 
WT
TmaDAH7PS  
The change in protein conformation for 
WT
TmaDAH7PS in the presence of Tyr 
can be more clearly detected when compared to the X-ray crystal structure.  
CRYSOL
86
 was employed to predict the theoretical scattering profile for 
WT
TmaDAH7PS from the X-ray crystal structure, and calculate the fit to the 
experimental SAXS profiles. For 
WT
TmaDAH7PS, the fit to the open structure 
(PDB 1RZM) was better than the fit to the closed structure (PDB 3PG9) in the 




 values of 0.26 and 1.90 respectively (figure 2.22). The 
superior fit to the open structure, suggests in the absence of ligand, aqueous 
WT
TmaDAH7PS adopts a similar average conformation to that observed in the 
crystal structure.  
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Figure 2.22: CRYSOL fit for 
WT
TmaDAH7PS SAXS profile in the absence of Tyr (blue 
rectangles), to the theoretical scattering profiles calculated from the open crystal structure (blue 




TmaDAH7PS, the fit to the closed structure was better than the fit to the 




 values of 0.62 and 1.93 respectively 
(figure 2.23). The superior fit to the closed structure suggests in the presence of 
ligand, aqueous 
WT
TmaDAH7PS adopts a similar conformation. 
Figure 2.23: CRYSOL fit for 
WT
TmaDAH7PS SAXS profile in the presence of Tyr (red 
rectangles), to the theoretical scattering profiles calculated from the open crystal structure (blue 








TmaDAH7PS, the fit to the open structure was worse than the fit to the 
closed structure in the absence of Tyr, with χ
2
 values of 1.04 and 0.69 respectively 
(figure 2.24). This is in direct contrast to 
WT
TmaDAH7PS and suggests that in the 
absence of ligand, aqueous 
V65P
TmaDAH7PS adopts an altered conformation that 
more closely resembles the closed structure. 
Figure 2.24: CRYSOL fit for 
V65P
TmaDAH7PS SAXS profile in the absence of Tyr (blue 
rectangles), to the theoretical scattering profiles calculated from the open crystal structure (blue 




TmaDAH7PS, the fit to the closed structure was also better than the fit to 
the open structure in the presence of Tyr, with χ
2
 values of 0.34 and 1.21 
respectively (figure 2.25). The superior fit to the closed structure, suggests in the 
presence of ligand, aqueous 
V65P
TmaDAH7PS adopts a similar conformation. 
Overall the conformation adopted by 
V65P
TmaDAH7PS, more closely resembles 
the closed structure in both the absence and presence of Tyr. CRYSOL fitting 
indicates little change in protein conformation for 
V65P
TmaDAH7PS in the 




Figure 2.25: CRYSOL fit for 
V65P
TmaDAH7PS SAXS profile in the presence of Tyr (red 
rectangles), to the theoretical scattering profiles calculated from the open crystal structure (blue 




TmaDAH7PS, the fit to the open structure was better than the fit to the 
closed structure in the absence of Tyr, with χ
2
 values of 0.13 and 1.56 respectively 
(figure 2.26). The superior fit to the open structure, suggests in the absence of 
ligand, aqueous 
P68A
TmaDAH7PS adopts a similar conformation as the crystal 
structure.  
                      
Figure 2.26: CRYSOL fit for 
P68A
TmaDAH7PS SAXS profile in the absence of Tyr (blue 
rectangles), to the theoretical scattering profiles calculated from the open crystal structure (blue 






TmaDAH7PS, the fit to the closed structure was better than the fit to the 
open structure in the presence of Tyr, with χ
2
 values of 0.25 and 2.01 respectively 
(figure 2.27). The superior fit to the closed structure, suggests in the presence of 
ligand, aqueous 
P68A
TmaDAH7PS adopts a similar conformation. CRYSOL fitting 
confirms a large change in protein conformation for 
P68A
TmaDAH7PS in the 
presence of Tyr. The change in conformation is more pronounced for 
P68A
TmaDAH7PS compared to 
WT
TmaDAH7PS.   
Figure 2.27: CRYSOL fit for 
P68A
TmaDAH7PS SAXS profile in the presence of Tyr (red 
rectangles), to the theoretical scattering profiles calculated from the open crystal structure (blue 
line) and the closed crystal structure (red line). 
 
2.9 Discussion 
The characterisation of WTTmaDAH7PS provides a comparison for the 
TmaDAH7PS linker variants, supporting the conclusions drawn from each 
result.
WT
TmaDAH7PS was successfully purified using an established procedure 




TmaDAH7PS is responsive to Tyr and Phe, with more potent inhibition 
achieved by Tyr. 
WT
TmaDAH7PS has high thermal stability in both the absence 
and presence of Tyr.  
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The allosteric regulation mechanism for 
WT
TmaDAH7PS, involves a large 
conformational change in the presence of Tyr. The scattering data is consistent 
with conformational change for 
WT
TmaDAH7PS, with decreased Rg, Dmax and Vp 
when Tyr is present. The conformational change was observed via overlay of the 
SAXS data, in the absence and presence of Tyr, which confirmed differences in 
the overall SAXS profiles. The conformational change for 
WT
TmaDAH7PS was 
more readily observed when comparing the SAXS data to the X-ray crystal 
structures, with 
WT
TmaDAH7PS adopting a similar average conformation to either 
the open crystal structure, in the absence of Tyr, or the closed crystal structure, 
when Tyr was present.  
The TmaDAH7PS linker variants were purified in the same manner as 
WT
TmaDAH7PS, with good success. Melting temperatures for the TmaDAH7PS 
linker variants were almost identical to 
WT
TmaDAH7PS, indicating the thermal 
stability of the enzymes had not been compromised by the individual linker 
mutations. Overall the kinetic properties amongst each enzyme were similar. Of 





which were calculated to be 8.4 ±0.10 s
-1 
and 8.1 ±0.10 s
-1 
respectively.  Each 
value is over 1.5 times greater than that of 
WT
TmaDAH7PS (5.5 ±0.050 s
-1
), 
suggesting altered flexibility of the linker region can impact enzyme activity. 
However, these results should not be over-interpreted, as 
WT
TmaDAH7PS 
displays some variability in kcat, evidenced by slight differences in the reported 
value.
82
 Nevertheless the increase in activity observed could be due to decreased 




TmaDAH7PS, altered flexibility of the linker may enable adoption of altered 
angles that favour alternate conformations and reduce time spent sampling the 
closed conformation.  
The reduced sensitivity of 
V65P
TmaDAH7PS to Tyr, suggests that reduction in 
flexibility has disrupted linker dynamics, impacting the ability of the enzyme to 
adopt the closed conformation in the presence of Tyr. Higher concentrations of 
Tyr still reduce enzyme activity, so the closed conformation, or a conformation 
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similar, may well be accessible. However, decreased flexibility may have reduced 
the level of stabilisation Tyr would normally provide, leading to a decrease in 
sampling of the closed conformation and a reduction in inhibition by Tyr. This 
result implies that either the relative stability of the open vs closed conformation 
has been altered, or that the closed conformation 
V65P
TmaDAH7PS can access, is 
not the same conformation that 
WT
TmaDAH7PS can access.  
What is clear is the impact the reduction of linker flexibility has on allosteric 
regulation of 
V65P
TmaDAH7PS. Fitting to the crystal structure models, suggests 
V65P
TmaDAH7PS adopts a similar conformation to the closed wild-type protein 
structure, in both the absence and presence of Tyr. However, the adopted 
conformation does not seem to enable full inhibition by Tyr.  
R64P
TmaDAH7PS exhibits the most similar characteristics to 
WT
TmaDAH7PS but 
is slightly less sensitive to Tyr and Phe. Potentially the reduced flexibility of 
position 64 is not as important as flexibility at position 65 for linker dynamics. 
The reduced linker flexibility of 
R64P
TmaDAH7PS has impaired the allosteric 
response somewhat but has had little effect on kinetic activity. Although SAXS 
analysis was unable to be performed for 
R64P
TmaDAH7PS, the similarity to 
WT
TmaDAH7PS enables prediction of gross conformational change in the 
presence of Tyr. However, the extent to which the fully closed conformation is 
adopted by 
R64P




TmaDAH7PS has improved sensitivity to Tyr. Like 
WT
TmaDAH7PS, the 
allosteric regulation mechanism for 
P68A
TmaDAH7PS involves a large 
conformational change, in the presence of Tyr. The scattering data is consistent 
with a change in conformation for 
P68A
TmaDAH7PS, with overlay of the SAXS 
data in the absence and presence of Tyr, highlighting significant differences in the 
overall SAXS profiles. CRYSOL fitting suggests 
P68A
TmaDAH7PS adopts a very 
similar conformation to the open and closed structures of the wild-type protein in 
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response to Tyr binding. Increased flexibility of the 
P68A
TmaDAH7PS linker has 
improved enzyme activity and the potency of the allosteric response.  
Biochemical characterisation and comparison of 
WT
TmaDAH7PS and the 
TmaDAH7PS linker variants, confirms the role of the linker region in allosteric 
regulation of TmaDAH7PS. The flexibility of the linker region appears to be 
integral to the mechanism of allostery employed by TmaDAH7PS, and alteration 










Protein Dynamics in Allosteric Regulation of Thermotoga 
maritima DAH7PS  
 
3.1 Introduction 
Gross conformational change and alterations in conformational flexibility have 
been associated with allostery and are defined as dynamic processes. For a 
protein, dynamic processes occur over a range of timescales, including very fast 
fluctuations of atoms, which take place on the picosecond timescale, to 
conformational rearrangement on the millisecond timescale.
71,87
 Over the last 
decade it has been realised that the molecular motions conferring allostery, take 
place with and without ligand binding, leading to proteins being described as a 
conformational ensemble of dynamic sub-states.
71,87
    
For TmaDAH7PS, the mechanism of allostery involves gross conformational 
change that may arise from alteration in protein dynamics, upon ligand binding. In 
silico techniques were therefore valuable to study in detail, changes in protein 
dynamics, occurring within the enzyme structure with Tyr binding. The modelling 
techniques employed to study molecular motion of TmaDAH7PS include 
molecular dynamics (MD) and targeted molecular dynamics (TMD), conducted 
with the software NAMD.
88
 The MD and TMD simulation work is presented in 
this chapter and supports the role of linker dynamics in the mechanism of 





3.2 Protein Dynamics 
Proteins are inherently dynamic biomolecules, which are able to sample an 
ensemble of conformations.
 71, 89
 Present within the protein ensemble are a number 
of pre-existing sub-states that resemble either the protein ground state, or in some 
cases a discrete conformer higher in energy.
90
 The occupancy of a particular sub-
state is dependent on the relative energy of the conformation the sub-state 
represents.
66
 Conformations lower in energy are sampled more often and are the 
predominant species in solution.
89-90
 The model of conformational selection is 
based upon the energy landscape theory, where different protein conformations 
exist in dynamic equilibrium.
89-91
 Each protein conformation is separated by an 
energy barrier and it is the relative energies of the conformations and their 
accessibility, as determined by the height of the energy barriers that separate 
them, that influences protein distribution over the free energy landscape.
89,91 
Ligand binding to a protein alters the relative energy of sub-states in the 
conformational ensemble. In addition, the frequency of sub-state sampling may be 
altered by ligand binding, shifting the energy profile of a protein and allowing 
different protein conformations to be accessed (Figure 3.1).
67,89
 A ligand might 
bind to only a few specific conformations and stabilise them. However, 
stabilisation modifies the entire ensemble and consequently the population of each 
sub-state.
66
 The binding interaction between a ligand and higher energy sub-state 
causes a population shift and leads to a change in observed conformer. The 
species that are occupied, and the time it takes for conformational change to 






Figure 3.1: Free energy landscape of a protein, with the protein ground state represented in purple 
and discrete protein conformers in blue. Similar protein conformations are coloured alike.  
 
The number of studies reporting a correlation between a protein’s equilibrium 
dynamics and structural changes involved in protein function, has increased in 
recent years, supporting the idea that proteins have an intrinsic ability to sample 
functional conformations that approximate those required for biological 
activity.
92-93
 The capacity of proteins to sample open and closed forms in the 
absence of ligand has been described, where the presence of ligand results in 
stabilisation of one form (usually closed), leading to a shift in the protein 
ensemble.
92
 The concept of “population shift” for a protein ensemble is the 
foundation for current understanding of allostery, determined by alteration in 





3.2.1 TmaDAH7PS Protein Dynamics 
The transition from the open to closed conformation of TmaDAH7PS is facilitated 
by protein dynamics. For TmaDAH7PS it is predicted that the open conformation 
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represents the protein ground state, and is occupied within the protein ensemble 
the majority of the time. The inactive conformer, observed upon Tyr binding, is 
likely higher in energy, so not occupied as frequently as the active, Tyr free 
conformer. 
When Tyr binds, the relative energy of individual sub-states within the protein 
ensemble changes, enabling the transition from the open to closed conformation.
94
 
The change in energy landscape in response to Tyr binding, results in a large 
average conformational adjustment for TmaDAH7PS.
46
 It seems likely that a 
dynamic equilibrium between the open and closed forms of TmaDAH7PS exists, 




The dynamic nature of TmaDAH7PS is pivotal to the mechanism of allosteric 
regulation exhibited by the enzyme.
48
 The transition from the open to closed 
conformation of TmaDAH7PS is facilitated by the flexible linker region, which 
enables the regulatory domains to re-position upon Tyr binding. The function of 
the linker region is likely not only for flexibility but may also contribute to an 
allosteric propagation pathway; where subtle changes in protein dynamics enable 
the closed conformation to be accessed, upon Tyr binding.
56,76
 A propagation 
pathway may be pre-encoded by the amino acids of the linker, so that successive 
states are encoded by the previous one, driving the conformational change of 




3.3 Molecular Dynamics 
Molecular dynamics (MD) is a computational simulation of the movement of 
atoms in a molecule over time. The time dependent behaviour of a molecular 
system is calculated by applying Newton’s equation of motion to the individual 
atoms of the molecular system.
88-95
 In a MD simulation the Newtonian equation 










where 𝑚𝑎 is the mass of atom 𝑎, 
𝜕2(𝑟𝑎)
𝜕𝑡2
 is the acceleration of atom 𝑎; in terms of 




the force acting on atom  𝑎, calculated from the total potential energy (𝑈𝑡𝑜𝑡𝑎𝑙) of 
every atomic position.
95
 𝑈𝑡𝑜𝑡𝑎𝑙 is dependent on each atomic position and is 
represented by the MD force field, which considers bonding and non-bonding 
interactions for the system.
96
  
For a MD simulation, periodic boundary conditions (PBC) are set to approximate 
an infinite system, via a unit cell.  PBC places the molecular system being 
modelled into a unit cell that is considered to have infinite images in space, so that 
any atom exiting the unit cell is replaced by its image, entering the opposite side 
of the unit cell.
97
  
In MD it is unpractical to calculate every long range interaction exactly and for 
MD simulations performed with NAMD, long range Van der Waals and 
electrostatic interactions are cut off at a distance of 25 Å.
88
 To calculate long 
range interactions, the particle-mesh Ewald (PME) method is used in combination 
with the periodicity of PBC.
98-99
 PME divides the total electrostatic interaction 





3.3.1 Molecular Dynamics Simulations for TmaDAH7PS 
MD simulations were conducted to examine the dynamic properties of the linker 
region for TmaDAH7PS. MD simulations were set up to survey the effect of 
reducing the flexibility of the linker for two systems: the open, ligand free system 
and the closed, Tyr bound system.  
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TmaDAH7PS crystal structures capturing both the open (PDB: 1RZM) and closed 
(PDB: 3PG9) conformation of the enzyme were used as starting points for each 
simulation. The tetrameric structure for each complex was generated from the 
associated dimer in the asymmetric unit, based on crystallographic symmetry. 
Preparation of each structure involved the removal of all ligands and replacement 




ions; as kinetic assays were performed in the 
presence of Mn
2+
. Open and closed systems were solvated in an explicit TIP3 
water box, which enabled movement of the regulatory domains; without 





 ions were added to each system to neutralise the overall net charge, with a 
minimum 5 Å distance between individual ions and between the enzyme and each 
ion.  
NAMD was used to carry out all MD simulations, using the CHARMM all atom 
parameter set 22.
88
 MD simulations were run using 1024 cores of the IBM Blue 
Gene/P computer from the University of Canterbury HPC supercomputing and 
services facility. Electrostatic interactions were calculated using the PME method, 
with a Van der Waals cut-off of 12 Å. Each simulation was performed at 1 
atmosphere and 363 K, the known optimal temperature for T. maritima activity. 
For each simulation an energy minimisation of 5000 steps, using the conjugate 
gradient energy minimisation method was run. Time steps of 2 fs were utilised 
and a trajectory written out every 100 ps.  
 









 A 335.1 ns trajectory for the open conformation of 
WT
TmaDAH7PS was kindly provided for analysis, enabling comparison to the 
V65P
TmaDAH7PS trajectories presented here. The MD simulation for the open 
conformation of 
WT
TmaDAH7PS, presents a relatively large increase in protein 
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backbone RMSD, with respect to the open crystal structure (Figure 3.2). Changes 
in RMSD occur rapidly, with RMSD greater than 8 Å relative to the starting 
structure, achieved within the first 50 ns of the simulation. For the remainder of 
the simulation the RMSD proceeds to oscillate between 8 Å and 10 Å, suggesting 
the protein undergoes a series of conformational rearrangements, without reaching 
an energy minimum that would suggest adoption of a stabilised conformer. 
                
Figure 3.2: Backbone RMSD of 
WT
TmaDAH7PS during a 335.1 ns MD simulation. 
 
Visual examination of the MD trajectory for the open conformation of 
WT
TmaDAH7PS confirmed conformational rearrangement of the regulatory 
domains throughout the simulation (Figure 3.3). In contrast, the core catalytic 
TIM barrels were relatively motionless, with limited conformational adjustment 
observed during the simulation. Conformational sampling was facilitated by the 
flexible inter-domain linker, which enabled the regulatory domains to explore a 
significant amount of the conformational space accessible to the protein. 
However, sampling of the fully closed conformation was unable to be observed 
via MD, which was predicted considering the high degree of freedom imparted by 
the flexible linker to the regulatory domains.   
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Figure 3.3: Conformational poses of 
WT
TmaDAH7PS during a 335.1 ns MD simulation of the 
open conformation. 
 




The initial MD simulation for the open conformation of 
V65P
TmaDAH7PS was run 
for 256.9 ns. Overall protein backbone RMSD values indicate relatively small 
deviations in backbone conformation, with respect to the open crystal structure 
(Figure 3.4). RMSD greater than 2 Å was achieved almost immediately upon 
initiating the simulation. However, as the simulation progressed the RMSD 
fluctuations were small, reaching a maximum of 3 Å before proceeding to 
oscillate around 2.5 Å.  
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Figure 3.4: Backbone RMSD of 
V65P




TmaDAH7PS, visual examination of the MD trajectory for the open 
conformation of 
V65P
TmaDAH7PS confirmed conformational rearrangement of 
the regulatory domains (Figure 3.5). However, the conformational adjustments 
were smaller for 
V65P
TmaDAH7PS, which appeared to sample a more limited 
conformational space. During the simulation regulatory domains from diagonally 
opposite monomers were not observed to interact, nor undergo movement in the 
direction necessary to adopt the closed conformation. It seems likely that the 
reduced flexibility of the linker has impaired the ability of 
V65P
TmaDAH7PS to 
adopt the closed conformation, or at least the range of conformations available to 
this modified protein.    
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Figure 3.5: Conformational poses of 
V65P
TmaDAH7PS during a 256.9 ns MD simulation of the 
open conformation. 
 
Second and third classical MD simulations were run for the open conformation of 
V65P
TmaDAH7PS, using the same parameters but different initial starting 
velocities to capture alternate conformational space explored by the enzyme. The 
MD simulations were run for 256.5 ns and 64 ns respectively. Protein backbone 
RMSD values indicate slightly larger deviations in backbone conformation, with 
respect to the open crystal structure (Figure 3.6-3.7). However, the RMSD 
oscillations were not as great as for the open conformation of 
WT
TmaDAH7PS. As 
before, neither MD simulation revealed interaction between the regulatory 
domains or movement of the regulatory domains in the direction required to adopt 




Figure 3.6: Backbone RMSD of 
V65P
TmaDAH7PS during a 256.5 ns MD simulation. 
 
Figure 3.7: Backbone RMSD of 
V65P




Figure 3.8: Conformational poses of 
V65P
TmaDAH7PS during 256.5 ns (above) and 64 ns (below) 
MD simulations of the open conformation. 
 




The closed conformation of 
V65P
TmaDAH7PS was simulated for 101.4 ns without 
Tyr bound and 67.1 ns with Tyr bound. Protein backbone RMSD values indicate 
relatively small deviations in backbone conformation, with respect to the closed 
crystal structure in both the absence (Figure 3.9) and presence of Tyr (Figure 
3.10). The RMSD increases slowly over the course of each simulation, oscillating 
between 1.5 Å and 2.5 Å.  
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Figure 3.9: Backbone RMSD of 
V65P
TmaDAH7PS during a 101.4 ns MD simulation, without Tyr 
bound. 
 
Figure 3.10: Backbone RMSD of 
V65P
TmaDAH7PS during a 67.1 ns MD simulation, with Tyr 
bound. 
 
Visual examination of the MD trajectory for each simulation revealed minimal 
displacement of the regulatory domains from starting atomic coordinates (Figure 
3.11). The regulatory domains remained in the closed position for the entirety of 
the simulation. Even in the absence of Tyr the closed conformation was still 
adopted, suggesting the closed conformation is relatively stable compared to the 
open conformation of 
V65P
TmaDAH7PS. Regulatory domain pairs above and 
below the tetramer appeared to interact normally with each other and with the Tyr 
68 
 
bound, indicating the linker substitution had little or no effect, on the ability of the 
enzyme to adopt the closed conformation and interact with Tyr. 
                       
Figure 3.11: Conformational poses of 
V65P
TmaDAH7PS during a 101.4 ns (above) and 67.1 ns 
(below) MD simulation of the closed conformation. 
 
A frame by frame distance comparison between the closed conformation with and 
without Tyr bound was performed by measuring the distance between the α-
carbons of His29 and Ser31, which are present in the pocket where Tyr binds and 
form a known hydrogen bond between adjacent regulatory domains (Figure 3.12). 
No significant difference in the distance between the residues was found. The 
average distance measured was 11.4 Å in the presence and absence of Tyr. This 
seems to indicate that the linker substitution had little or no effect on Tyr binding, 






                                               
Figure 3.12: Cartoon representation of the hydrogen bond formed between His29 (purple) and 




3.4 Targeted Molecular Dynamics 
Targeted molecular dynamics (TMD) is a computational simulation where the 
atoms are guided towards a final “target” structure, by continuously decreasing 
the distance to the target via constraints.
101
 For each time step the distance 
between the current coordinates and the target structure is calculated, following 
alignment of the two structures. The force applied to each atom is calculated from 
the potential energy gradient: 
𝑈𝑡𝑜𝑡𝑎𝑙 =  
1
 2 
 𝑘/𝑁 [𝑅𝑀𝑆(𝑡) − 𝑅𝑀𝑆∗(𝑡)]2 
where the spring constant (𝑘) is scaled down by the number of atoms (𝑁) being 
simulated, 𝑅𝑀𝑆(𝑡) is the RMS distance between the current and target 
coordinates over time (𝑡), and 𝑅𝑀𝑆∗(𝑡) evolves linearly from the initial RMSD to 
the final RMSD, reached at the final time step.  
70 
 
For TMD simulations the transition between conformational states is enforced 
independently of the height of the energy barriers that separate each conformer.
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The constraints placed on the atoms of the simulated system, ensure the RMSD 
between the final structure adopted and the target structure, is virtually zero 
within the simulation run time.
103
 This enables TMD to calculate a reaction 
pathway between two distinct conformational states. For a typical TMD transition, 
large-scale changes occur earlier in the simulation, followed by small-scale 
alterations; leading to some bias in the order of conformational rearrangement.
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Despite this limitation TMD has proven a useful method for evaluating 
conformational transitions and has been used to assess allostery.
103
   
 
3.4.1 Targeted Molecular Dynamics Simulations for 
TmaDAH7PS 
TMD was utilised to investigate the transition from the fully open to fully closed 
and fully closed to fully open conformation of TmaDAH7PS. TmaDAH7PS 
crystal structures capturing the open (PDB: 1RZM) and closed (PDB: 3PG9) 
conformation of the enzyme were prepared as above, for the classical MD 
simulations; and were used as either the initial starting, or final target structure, 
depending on the direction of the TMD simulation. TMD simulations were run by 
applying a constant force (600 kcal/mol/Å
2
) to the alpha carbon, of residues 1 to 
80, which encompass the linker and regulatory domain of TmaDAH7PS.  
The TMD simulation for the transition from the open to closed conformation of 
WT
TmaDAH7PS was setup to occur over approximately 10 ns of classical MD 
simulation time. Protein backbone RMSD values indicate large deviations 
initially, corresponding to large global motions, which are characteristic of TMD. 
The RMSD fluctuates less as the closed conformation becomes more closely 
adopted, due to smaller local adjustments (Figure 3.13).  
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Figure 3.13: Backbone RMSD of 
WT
TmaDAH7PS during TMD simulation for the transition from 
the open to closed enzyme conformation. 
 
The TMD simulation for the transition from the closed to open conformation of 
WT
TmaDAH7PS was setup to occur within the same time period as the open to 
closed TMD simulation. Protein backbone RMSD values indicate large deviations 
throughout the simulation (Figure 3.14). The decreased RMSD observed for the 
second half of the simulation corresponds to more pronounced local 
rearrangements for the open conformation.  
Figure 3.14: Backbone RMSD of 
WT
TmaDAH7PS during TMD simulation for the transition from 




Visual examination of the TMD trajectories suggests a reasonably well defined 
path exists between the open and closed conformations of 
WT
TmaDAH7PS 
(Figure 3.15). Some overlap of the conformational space explored during the 
classical MD and TMD simulations was observed, supporting the intermediate 
conformations characterised for 
WT
TmaDAH7PS.  
Figure 3.15: Conformational poses of 
WT
TmaDAH7PS during a TMD simulation of the open to 
closed (above) and closed to open (below) conformation. 
 
3.4.2 Dihedral Angles for Amino Acids of the Linker Region of 
TmaDAH7PS 
For a protein, dihedral angles describe the rotation around the polypeptide 
backbone, about the Cα – N bond (φ) and the Cα – C bond (ψ). Over the course of 
the TMD simulations φ and ψ angles for the amino acids of the linker region were 
plotted, to explore which amino acids contribute to the movement of the 




TmaDAH7PS. The φ and ψ values for each amino acid were averaged over the 
four protein chains of the tetramer and plotted for analysis.   
The dihedral angle plots of the linker residues Arg64, Val65, Leu66 and Lys67 
displayed large fluctuations in φ and/or ψ, over the course of the TMD simulation. 
The alterations in φ and ψ angles suggest each residue is potentially involved in 
the movement of the regulatory domains, during the transition from the open to 
closed conformation of 
WT
TmaDAH7PS.  
The ψ angle of Arg64 fluctuates throughout the TMD simulation, with a large 
rotation of the residue observed approximately midway through the transition 
from the open to closed conformation of 
WT
TmaDAH7PS (Figure 3.16). The 
rotation of Arg64 is similar to Val65 and occurs within the same time period 
during the TMD simulation (Figure 3.17). This may indicate that Arg64 and 
Val65 are required to facilitate adoption of the closed conformation of the 
enzyme. Val65 undergoes the greatest fluctuation in φ and ψ angles compared to 
other linker residues. The dramatic changes in dihedral angles implicate Val65 in 
protein dynamics, which are likely essential in the transition from the open to 
closed conformation of 
WT
TmaDAH7PS.  












Leu66 and Lys67 also exhibited fluctuations in φ and ψ angles. However, unlike 
Arg64 and Val65 there was no defined rotation observed midway through the 
TMD simulation. Leu66 undergoes dramatic changes in ψ angle as the closed 
conformation becomes more closely adopted (Figure 3.18). Interestingly Lys67 
displayed sharp alterations in both φ and ψ angles around the midway point of the 
TMD simulation but otherwise these angles remained relatively constant (Figure 
3.19). It seems likely that the minor fluctuations of Lys67 may be linked to the 
more dramatic changes occurring in the φ and ψ angles of Arg64, Val65 and 
Leu66.  












The φ and ψ angles of Arg64, Val65, Leu66 and Lys67 indicate each amino acid 
is important for linker dynamics. The movement of the regulatory domains is 
likely facilitated by each of the minor adjustments each amino acid undergoes, 
enabling the transition from the open to closed conformation of 
WT
TmaDAH7PS. 
Observations made from the MD and TMD simulations were used in combination 
with initial biochemical characterisation of 
V65P
TmaDAH7PS to select additional 
linker variants to investigate. The mutations R64P, L66P and K67P were expected 
to act in a similar manner to the V65P linker substitution, where a reduction in 
flexibility of the linker region might lead to enhanced enzyme activity and/or a 
reduced response to Tyr. Based on the similarity of the dihedral angle plots of 
Arg64 and Val65, 
R64P
TmaDAH7PS was selected over other possible linker 
residues for mutation.  
 
3.5 Discussion 
MD simulations are useful in the study of gross conformational changes and 
conformational flexibility, as biomolecules are able to be assessed on an atomic 
level. 
WT
TmaDAH7PS has been studied previously via MD by Lang,
100
 whose 
results corroborate those reported here for 
WT
TmaDAH7PS, as well as providing 
context for the 
V65P
TmaDAH7PS simulations. Classical MD simulations for the 
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open conformation of 
WT
TmaDAH7PS, present greater deviations in protein 
backbone RMSD, relative to the open crystal structure, when compared to 
V65P
TmaDAH7PS, indicative of greater conformational adjustment for 
WT
TmaDAH7PS. Inspection of the simulation trajectories revealed conformational 
rearrangement of the regulatory domains, facilitated by the flexible inter-domain 
linker for 
WT
TmaDAH7PS, with indication of the transition towards the closed 
conformation. Sampling of the fully closed conformation is likely unachievable 
via classical MD, due to the timescales able to be accessed. However, interaction 
of the 
WT
TmaDAH7PS regulatory domains was observed within the simulation 
time achieved for 
V65P
TmaDAH7PS, suggesting the restricted linker flexibility of 
V65P
TmaDAH7PS, has greatly impacted the enzyme’s ability to adopt the closed 
conformation, as no interaction of the regulatory domains was observed for 
V65P
TmaDAH7PS. 
The classical MD simulations for 
V65P
TmaDAH7PS do not reveal adoption of the 
closed conformation or any conformation that resembles those adopted by 
WT
TmaDAH7PS. MD simulations for the open conformation of 
V65P
TmaDAH7PS 
instead reveal open conformations, where the regulatory domains proceed only so 
far towards the central axis of the tetramer, before swinging back towards more 
open conformations. Again, the time scale able to be accessed with classical MD, 
limits the conformations able to be observed. However, the conformational space 
explored by 
V65P
TmaDAH7PS appears to be restricted by the less flexible linker 
region. The 
V65P
TmaDAH7PS linker seems to facilitate the adoption of 
conformers, which do not easily access the closed enzyme conformation.  
As MD simulations are limited by the time scale accessible, TMD simulations 
were utilised to accelerate conformational change, enabling computational 
observation within a practical time frame. The TMD simulation for the transition 
from the open to closed conformation of 
WT
TmaDAH7PS, resulted in large 
deviations in protein backbone RMSD values initially, with less fluctuation as the 
closed conformation became more closely adopted. In comparison, the transition 
from the closed to open conformation of TmaDAH7PS, presented greater 
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deviations in protein backbone RMSD near the end of the simulation, as the open 
conformation became more closely adopted. The difference in protein backbone 
RMSD values for each TMD simulation highlights the inconsistences that occur 
for TMD simulations, due to propensity to perform large scale, global motions 
prior to small scale, local motions. The TMD simulations therefore represent only 
a possible route to the transition between the open and closed enzyme forms and 
do not represent the true transitional pathway, which connects the open and closed 
conformations.  
Analysis of the dihedral angles for each amino acid of the linker region, 
implicates residues that impart flexibility to the linker. The flexibility of the linker 
is likely essential for linker dynamics and propagation of the allosteric signal 
between the regulatory domains and catalytic TIM barrel. In particular Val65 
undergoes dramatic changes in φ and ψ angle over the course of the TMD 
simulation, so appears important for linker dynamics. The disruption of linker 
dynamics is therefore predicted to be the cause of the altered conformational 
sampling observed via classical MD, for 
V65P
TmaDAH7PS. The altered 
conformers adopted by 
V65P
TmaDAH7PS support the role of linker dynamics in 

















Discussion of Linker Dynamics in Allosteric Regulation of 
Thermotoga maritima DAH7PS 
 
4.1  Introduction 
Perspective surrounding the role of inter-domain linkers has shifted from simple 
covalent attachment between discrete protein domains, to include the possibility 
of significant function, within complex allosteric signalling networks. Multiple 
studies support the role of linkers in allostery, reporting transitions between 
functional protein states that arise from linker dynamics.
104,105,106
 Well studied 
examples include protein kinase A (PKA), which functions in cell signalling via 
phosphorylation of numerous cell targets, and the Hsp70 family of heat shock 
proteins (HSPs). 
 
For PKA, the regulatory domain involved in ligand binding is connected by a 
flexible linker, which in the absence of cAMP is positioned over the active site of 
the catalytic subunit.
105
 Upon cAMP binding the linker becomes more flexible and 
repositions, stabilising a conformation of the regulatory domain that binds weakly 
to the catalytic subunit. Stabilisation releases inhibition of the catalytic subunit, 
enabling kinase release .
105
 The PKA linker, functions in population shift; altering 
the equilibrium that exists between the active and inactive enzyme forms, 




Hsp70 chaperone proteins also possess a dynamic linker, which functions in 
allosteric communication between the C-terminal substrate binding domain (SBD) 
and the N-terminal nucleotide binding domain (NBD).
106
 The inter-domain linker 
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has been reported to act as a molecular switch, where upon substrate binding the 
linker is able to interact with the NBD, resulting in enhanced ATPase activity.
106
 
The Hsp70 linker, functions in allosteric coupling between the SBD and NBD; 
transducing allosteric signals between the domains in both directions, to control 
enzyme activity.  
This chapter explores the role of linker dynamics in allosteric regulation of 
TmaDAH7PS, through discussion of the results presented in chapters two and 
three. When considered together, the results provide a more comprehensive 
understanding of the dynamic motions of TmaDAH7PS and the impact of linker 
dynamics on TmaDAH7PS allostery.    
 
4.2  Role of Linker Dynamics in Allosteric Regulation of 
TmaDAH7PS 
For TmaDAH7PS, the flexible inter-domain linker plays an important role in 
allosteric regulation of the enzyme. The inherent properties of the linker facilitate 
the adoption of two discrete conformers, which are significant for biological 
function. The transition between the open and closed conformation of 
TmaDAH7PS is possible due to the flexibility of the linker. However, re-
distribution of the protein ensemble is controlled by dynamic properties, which 
are associated with ligand binding and transfer of the allosteric signal through the 
enzyme.  







differ chemically from 
WT
TmaDAH7PS, by single amino acid substitutions within 
the linker region. Individual substitutions alter linker flexibility and consequently 
dynamic properties of the variant enzyme. Characterisation of each TmaDAH7PS 
linker variant provides a means to assess the role of the linker, in TmaDAH7PS 
function and regulation.  
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TmaDAH7PS catalytic activity can be altered, via either decreased or increased 




TmaDAH7PS. kcat is a measure of the number of 




TmaDAH7PS involve single amino acid substitutions 
within the linker, the enhanced kcat may be attributed to a greater rate of substrate 
binding and/or product release, where the enhanced rate could arise from reduced 
sampling of the closed conformation of TmaDAH7PS.    





TmaDAH7PS supports the idea that for 
WT
TmaDAH7PS, the closed conformation is accessible but is far less frequented 
than the open conformation when Tyr is absent. Alterations to linker flexibility 
appear to exacerbate the equilibrium bias, reducing sampling of the closed 




TmaDAH7PS are more catalytically active. 




TmaDAH7PS is supported by the classical MD simulations. MD simulations 
for 
V65P
TmaDAH7PS do not predict adoption of the closed conformation, or any 
conformation that resembles the closed form. The altered flexibility of the linker 
appears to modify the conformational space explored by the enzyme, reducing the 
time spent sampling conformations that approximate the closed form. 
The altered conformers adopted by 
V65P
TmaDAH7PS, supports the role of linker 
dynamics in the mechanism of allostery for TmaDAH7PS. During the TMD 
simulations of the wild-type protein, Val65 underwent dramatic changes in φ and 
ψ angle, which were predicted to be related to linker dynamics associated with 
TmaDAH7PS allostery. The disruption to linker dynamics is likely the basis for 





The reduced sensitivity of 
V65P
TmaDAH7PS to Tyr, also suggests the reduction in 
flexibility has disrupted linker dynamics, as the ability of the enzyme to adopt the 
closed conformation in the presence of Tyr has been impacted. The scattering data 
for 
V65P
TmaDAH7PS, confirmed minor conformational change in the presence of 
Tyr, with overlay of the SAXS data producing similar SAXS profiles. The 
conformation adopted by 
V65P
TmaDAH7PS, does not seem to enable full 
inhibition by Tyr. This suggests 
V65P
TmaDAH7PS can either not access the closed 








TmaDAH7PS has improved sensitivity to 
Tyr. Like 
WT
TmaDAH7PS, the allosteric regulation mechanism for 
P68A
TmaDAH7PS seems to involve gross conformational change in the presence 
of Tyr. Overlay of the SAXS data in the absence and presence of Tyr is consistent 
with a change in conformation for 
P68A
TmaDAH7PS. Fitting to the known 
structures of the wild-type enzyme using Crysol, suggests 
P68A
TmaDAH7PS 
adopts virtually identical conformations to the open and closed enzyme structures 
in response to Tyr binding.  
Increased flexibility of the 
P68A
TmaDAH7PS linker has improved enzyme activity 
and the potency of the allosteric response. The increased flexibility seems to 
enable adoption of both the open and closed enzyme conformations. For 
P68A
TmaDAH7PS, linker dynamics result in more exclusive sampling of both the 
open and closed enzyme conformations, dependent on the absence or presence of 
Tyr. This suggests the equilibrium between the two discrete conformers remains 




4.3  Conclusion 
The flexibility of the linker is integral to the mechanism of allostery employed by 
TmaDAH7PS. Alteration to linker flexibility can significantly impact linker 
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dynamics, which are essential for the transition between discrete functional states. 
The dynamic properties of the linker control the position of the equilibrium 
between the open and closed enzyme forms. Adjusting linker flexibility impacts 
the equilibrium, generating variant enzymes with distinct catalytic and regulatory 











Summary of Thesis and Future Work 
 
Protein molecules are highly dynamic species, which exist as an ensemble of 
protein conformations that readily interconvert, via dynamic fluctuations. The role 
of inter-domain linkers in allostery has become more recognised over the past 
decade, with multiple studies reporting transitions between functional protein 
states, attributed to linker dynamics.
104-107
 In this thesis the biochemical 
characterisation of TmaDAH7PS and several TmaDAH7PS linker variants is 
described. The results presented here for 
WT
TmaDAH7PS align well with other 
studies performed on this enzyme, both within the Parker research group and by 
other research groups; providing context for each of the TmaDAH7PS linker 
variants discussed during this work.
33,82






TmaDAH7PS confirm the 
importance of linker flexibility for adoption of discrete functional conformers, and 
the role of linker dynamics in conformational selection and allosteric propagation.   
 
5.1  Modifying Linker Flexibility Impacts TmaDAH7PS Activity 





TmaDAH7PS have increased kcat in 
comparison to 
WT
TmaDAH7PS, indicating that either a decrease or increase in 
linker flexibility can impact TmaDAH7PS activity. The enhanced catalytic rate is 
predicted to be caused by a shift in the equilibrium position between discrete 
functional states. The equilibrium may favour the open conformer, resulting in 
decreased sampling of the closed conformation and therefore an increase in 
enzyme activity. Decreased sampling of the closed conformation is supported by 
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the MD simulations, which confirm the adoption of open-like conformers by 
V65P
TmaDAH7PS. Modifying linker flexibility appears to adjust the 





TmaDAH7PS are less sensitive to inhibition by Tyr, 
suggesting decreased linker flexibility has disrupted linker dynamics, impairing 
the ability of each enzyme to adopt the closed conformation. The response of 
R64P
TmaDAH7PS to Tyr was more significant than 
V65P
TmaDAH7PS however, 
accentuating the importance of Val65 in the dynamic motions associated with 
adoption of the open and closed conformations. In contrast 
P68A
TmaDAH7PS was 
more sensitive to inhibition by Tyr, with increased flexibility of the linker aiding 
adoption of the closed conformation when Tyr was present. The experimental 
results suggest the dynamic motions required to transition between the open and 
closed conformations, remain intact for 
P68A
TmaDAH7PS.   
 
5.2  Linker Dynamics Facilitate Allosteric Regulation of 
TmaDAH7PS 
The allosteric regulation mechanism of TmaDAH7PS is significantly impaired by 
reducing the flexibility of the linker. The absence of conformational change in the 
presence of Tyr for 
V65P
TmaDAH7PS was confirmed by SAXS, where overlay of 
the SAXS data collected in the absence and presence of Tyr, generated similar 
SAXS profiles, which deviate little from one another. The conformation adopted 
by 
V65P
TmaDAH7PS does not enable full inhibition by Tyr. It appears that linker 
dynamics have been disrupted for 
V65P
TmaDAH7PS, so that the closed 
conformation adopted by 
WT
TmaDAH7PS upon Tyr binding, is unable to be 
accessed by 
V65P
TmaDAH7PS.   
For 
P68A
TmaDAH7PS the allosteric regulation mechanism involves gross 
conformational change upon Tyr binding. The increased flexibility of the linker 
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enables adoption of both the open and closed enzyme conformations. Fitting to 
the existing structures of the wild-type protein by Crysol, matches the SAXS 
profiles for 
P68A
TmaDAH7PS in the absence and presence of Tyr, to the open and 
closed crystal structures with high fidelity. 
P68A
TmaDAH7PS linker dynamics 
facilitate the adoption of both the open and closed conformations. However, the 
increased flexibility has influenced dynamic motions, so that discrete functional 
conformations are sampled more exclusively, dependent on the absence or 
presence of Tyr. 
 
5.3 Future Work 
The role of linker dynamics in allosteric regulation of TmaDAH7PS could be 
further elucidated by several key studies, some of which were attempted but were 
unable to be achieved within the timeframe of this thesis. The studies outlined 
here may provide key evidence, required to answer the following questions.  
What is the Structure of 
V65P
TmaDAH7PS? 
The structure of 
V65P
TmaDAH7PS in the presence of Tyr was sought for 




TmaDAH7PS, the crystal for the closed structure was obtained by sitting-drop 
vapour diffusion, grown from a reservoir containing 20% (w/v) polyethylene 
glycol 3350, 0.2 M ammonium nitrate and 0.02% (w/v) sodium azide.
82
 Attempts 
were made to crystallise 
V65P
TmaDAH7PS in the absence and presence of Tyr, 
using the hanging-drop vapour diffusion method, screening similar conditions to 
WT
TmaDAH7PS. Unfortunately, the initial screens proved unsuccessful but higher 
throughput screening may enable detection of conditions under which the protein 
will crystallise. Structural information for 
V65P
TmaDAH7PS would improve the 
validity of the results presented here, particularly Crysol fitting of the 
V65P
TmaDAH7PS SAXS data to the open and closed crystal structures and the 
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MD simulations, which would benefit from the 
V65P
TmaDAH7PS crystal structure 
as opposed to the 
WT
TmaDAH7PS crystal structure.   
Does 
V65P
TmaDAH7PS Bind Tyrosine? 
Isothermal titration calorimetry (ITC) is a technique that enables determination of 
the thermodynamic parameters of interactions in solution.
108
 As ITC provides a 
direct measure of the heat changes associated with ligand binding in solution, the 
technique was employed to study binding interactions between Tyr and 
TmaDAH7PS and the TmaDAH7PS linker variants; with particular interest in the 
binding properties of 
V65P
TmaDAH7PS. Although unsuccessful, the ITC analysis 
attempted during this research is presented here, to provide a basis for future 
optimisation of the TmaDAH7PS – Tyr system, which will be invaluable for 
determination of the molecular detail surrounding TmaDAH7PS allostery.  
For 
WT
TmaDAH7PS a range of protein and ligand concentrations were trialled 
with limited success. Best results were obtained when a 1 mM solution of Tyr was 
titrated into 155 µM 
WT
TmaDAH7PS and fit to a one-site binding model. 
However, low sigmoidicity of the binding curve indicated the fit was inadequate 
to generate usable binding data. Sigmoidicity of the binding curve may be 
improved by optimising the relative concentrations of protein and ligand. From 
analysis of the conditions attempted previously, a lower concentration of Tyr or 
smaller injection volume may increase the number of peaks observed before 
saturation, improving sigmoidicity of the binding curve and accuracy of the 
thermodynamic parameters.   
A number of protein and ligand concentrations were also trialled for 
V65P
TmaDAH7PS, with little improvement. A more extensive range of both 
protein and ligand concentrations were evaluated for 
V65P
TmaDAH7PS. However, 
the binding curves generated had little sigmoidicity, when fit to a one-site binding 
model. Tyr concentrations from 0.3 to 3 mM were assessed, at a variety of protein 





TmaDAH7PS; although it is possible a higher Tyr or lower protein 
concentration may improve the quality of fit to a one-site binding model.  
Initial characterisation weakly suggests Tyr binds to 
V65P
TmaDAH7PS, with a Kd 
within the same concentration range as 
WT
TmaDAH7PS obtained. However, with 
the quality of data at present, an accurate Kd is unable to be reported. It is unlikely 




TmaDAH7PS ITC data. The TmaDAH7PS – Tyr system 
proves difficult to assess by ITC and this may be for a number of reasons, 
including mutually exclusive conditions required to optimise Kd and ΔH. Factors 
to consider when moving forward include the heat of dilution, buffer selected, pH 
and temperature of the experiment.  
A relatively large heat of dilution was observed that in part, is likely due to 
mixing effects associated with the properties of Tyr but also factors, such as the 
buffer Tyr is dissolved in. Buffer mismatch between the macromolecule in the 
sample cell and the ligand injected, can result in large heats being produced, 
which mask potential binding interactions. Extensive dialysis of TmaDAH7PS 
enzymes into the appropriate buffer was performed. However, purification of each 
enzyme, using the selected buffer for ITC, may be more effective in preventing 
buffer mismatch between TmaDAH7PS and Tyr.  
Further optimisation of the buffer and pH employed may also improve quality of 
the ITC data. Buffers with a low enthalpy of ionisation should be utilised to 
minimise artificial heat production.
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 The temperature at which the experiment is 
conducted can also impact the heats produced, so the experiment was repeated at 
60 °C. Unfortunately, no improvement was observed. As TmaDAH7PS is a hyper-
thermophile elevated temperatures may enhance quality of the binding data 
obtained. However, additional evaluation at a range of temperatures is required.  
Elucidation of the role of the inter-domain linker, in the allosteric regulation 
mechanism of TmaDAH7PS would benefit from molecular detail regarding the 
binding interactions between Tyr and TmaDAH7PS. In particular the contribution 
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of linker dynamics to TmaDAH7PS allostery would be supported by ligand 
binding information, which would provide more definitive evidence for 
conformational selection and allosteric propagation, resulting from perturbation of 
linker dynamics.   
Can the Open/Closed Response be Triggered Without the TIM 
Barrel Scaffold? 
The creation of a synthetic dimer between two of the regulatory domains of 
TmaDAH7PS, could confirm whether the open/closed response is possible 
without the TIM barrel scaffold. If the regulatory domains are connected together 
with a flexible inter-domain linker, the synthetic dimer may act as a functional 
unit, which in the absence and presence of Tyr, could switch between the open 
and closed forms. Linkers of varying lengths could be trialled to determine 
whether the open/closed response could be triggered for the regulatory domains. 
Synthesis of an open/closed functional unit may enable transfer to a completely 


















6.1 General Methods 
 
6.1.1 Protein Structures 
The PyMOL Molecular Graphics System (Version 1.8, Schrödinger LLC) was 




6.1.2 Sequence Alignments 
Multiple amino acid sequence alignments were generated using the Clustal 
Omega web server (http://www.ebi.ac.uk/Tools/msa/clustalo/).110  
 
6.1.3 Purified Water 
All water used for experimental procedures was purified by a Millipore Milli-Q 
water system and is referred to as Milli-Q. Milli-Q required for molecular biology 






6.1.4 Chelexed Milli-Q 
Chelex® 100 resin (Bio-Rad) was used to remove metal ions from solution. The 
manufacturer’s instructions for the batch method were followed, where the resin 
was added to the Milli-Q solution, left to stir overnight and filtered (0.2 μm) prior 
to use.  
 
6.1.5 pH Determination 
The pH of all buffer solutions was measured using a Denver UB-10 Ultrabasic pH 
meter at room temperature. Desired pH was achieved via the addition of either 
HCl or NaOH, at a concentration of 1 M or 10 M, to the buffer solution.  
 
6.1.6 Antibiotic Stocks 
Ampicillin (100 mg/mL) stock solutions were prepared in Milli-Q, filtered (0.2 
μm), aliquoted into micro-centrifuge tubes under sterile conditions and stored at -
80 °C.  
 
6.1.7 Media 
Super optimal broth with catabolite repression (SOC) media (2% (w/v) tryptone, 
0.05% (w/v) yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 20 mM 
glucose) was prepared in Milli-Q, with the addition of each component, excluding 
MgCl2 and glucose. The mixture was autoclaved at 121 °C, 15 psi for a minimum 
of 20 minutes and aliquoted into sterile micro-centrifuge tubes before the addition 
of filter sterilised MgCl2 and glucose immediately prior to use.  
Cell cultures were grown in LB media (10 g/L tryptone, 5 g/L yeast extract, 10 
g/L NaCl) prepared in Milli-Q at a concentration of 20 g/L. LB media was 
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sterilised by autoclaving at 121 °C, 15 psi for a minimum of 20 minutes prior to 
use. LB agar plates were prepared via the addition of agar (25 g/L) to LB. LB agar 
was heated to boiling, followed by incubation at 60 °C for one 1 hour. Ampicillin 
(100 mg/mL) was added immediately prior to pouring. 
 
6.1.8 Chemically Competent Cells 
All chemically competent cells were commercially prepared and supplied 
(Invitrogen or Novagen).  
 
6.1.9 Transformation 
Chemically competent cells (50 μL aliquots) were thawed on ice prior to the 
addition of purified plasmid (2 μL). The cells were incubated on ice for 30 
minutes before a 30-45 second heat shock at 42 °C. The cells were incubated on 
ice for a further 2 minutes, prior to the addition of SOC media (250 μL) and 
incubated for 1 hour at 37 °C, 180 rpm. Transformed cells (50-200 μL) were 
spread on a pre-warmed LB agar plate, supplemented with ampicillin and 
incubated overnight at 37 °C.  
 
 6.1.10 Polymerase Chain Reaction 
Polymerase chain reactions (PCRs) were performed by following the standard 
protocol for Phusion® High Fidelity DNA Polymerase (Thermo Scientific). The 
PCR reaction mixture (50 µL) consisted of 1x reaction buffer, 
deoxyribonucleotide triphosphates (dNTPs) (200 µM), forward and reverse 
primers (0.5 µM), template DNA (50-250 ng/gDNA) and Phusion® High Fidelity 
DNA Polymerase (10 µL). A two or three step thermocycling protocol was 
employed for each reaction.  
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6.1.11 Agarose Gel Electrophoresis 
Separation of DNA fragments was achieved via agarose gel electrophoresis. 
Agarose gels were prepared using a solution of 1% (w/v) LE agarose (Seakem) in 
50x Tris base-acetic acid-EDTA (TAE) buffer (40 mM Tris-HCl, 20 mM glacial 
acetic acid, 2 mM EDTA). The solution was heated until the agarose was 
completely dissolved then incubated at 60 °C, before the addition of SYBR® Safe 
DNA Gel Stain (Invitrogen). Samples were mixed with 6x loading buffer (60 mM 
Tris-HCl, 60 mM EDTA, 0.02% (w/v) orange G, 0.05% (w/v) xylene cyanol FF, 
60% glycerol) before loading to gel wells. A 1 kB Plus DNA ladder (Invitrogen) 
was run alongside the samples for size comparison. Hand-cast gels were run in 1x 
TAE buffer using a Mini-Sub cell GT (Bio-Rad), at 85 V for 45 minutes. Images 
were captured using a Molecular Imager® Gel DocTM XR, visualised under UV 
(302 nm).  
 
6.1.12 Restriction Enzyme Digest 
High fidelity restriction enzymes (New England Biolabs) were utilised to digest 
circular vectors. Plasmid DNA (1 µg) was combined with 10x Cutsmart® Buffer, 
restriction enzyme (1 µL) and Milli-Q to a total volume of 50 µL before the 
restriction enzyme digest mixture was incubated at 37 °C for 1 hour. The 
restriction enzymes were then denatured at 80 °C for 20 minutes. The digested 
vector was purified by gel electrophoresis prior to use.  
 
6.1.13 Plasmid Extraction and Purification 
A 5 mL LB preculture, supplemented with ampicillin was inoculated with a single 
colony of either Stellar
TM
 or E. coli BL21*(DE3) chemically competent cells 
(Clontech), which had been transformed with the desired plasmid. Cells were 
grown overnight at 37 °C, 180 rpm. The cells were harvested and plasmids 
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extracted using a Nucleospin® Plasmid Easy Pure Kit (Clontech) and the 
concentration of purified plasmid measured using a Nanodrop-1000 
spectrophotometer under UV (260 nm).  
 
6.1.14 DNA Sequencing 
DNA sequencing services were provided by Macrogen. For the sequencing 
reactions approximately 200 ng of plasmid and 3.2 µM sequencing primers were 
supplied.  
 
6.1.15 Glycerol Stocks 
Glycerol stocks were prepared by combining an aliquot of preculture growth with 
20% (v/v) glycerol, under sterile conditions. The glycerol stock was mixed 
thoroughly before transfer to a sterile micro-centrifuge tube, which was snap 
frozen in liquid nitrogen and stored at -80 °C.  
 
6.1.16 E. coli Cell Culture Growth 
For E. coli cell cultures a preculture was prepared from 50 mL of LB media, 
supplemented with ampicillin and inoculated with a glycerol stock scraping. The 
preculture was incubated overnight at 37 °C, 180 rpm. The preculture was used to 
inoculate 1 L of LB media, supplemented with ampicillin. 1 L cultures were 
grown in baffled flasks at 37°C, 180 rpm until mid-logarithmic phase (OD600 0.4-
0.8 AU). Protein expression was induced with IPTG (Roche), which was added to 
cultures at a final concentration of 1 mM. Cells were harvested approximately 4 
hours after incubation with IPTG (37 °C, 180 rpm) by centrifugation (12,000 g, 4 




6.1.17 Cell Lysis 
The cell pellet was re-suspended in approximately 20 mL of lysis buffer (10 mM 
1,3-(tris(hydroxyl-methyl)-methylamino)propane (BTP), 1 mM EDTA, 100 mM 
KCl, 200 µM PEP, pH 7.3) and cells lysed by sonication, using an Omni-Ruptor 
4000 Ultrasonic Homogenizer (Omni International). The cell pellets were 
sonicated in a beaker surrounded by ice and subjected to 3x 5 minute rounds at 
80% power, 30% pulsation followed by 3x 5 minute rounds at 80% power, 40% 
pulsation. The cell debris was removed by centrifugation (40,000 g, 4 °C for 30 
minutes) and the supernatant incubated with 2 µL Benzonase® Nuclease (Sigma 
Aldrich) for 10 minutes.   
 
6.1.18 Heat Treatment 
Heat treatment of the cell lysate was performed using a heat block at 70 °C, for 30 
minutes. The cell lysate was aliquoted into test tubes and covered with Parafilm 
M® prior to heating. Following the heat treatment test tubes were left to cool to 
room temperature, before dilution with lysis buffer to improve protein collection. 
Heat debris was removed by centrifugation (40,000 g, 4 °C for 30 minutes) and 
the supernatant collected for further purification.  
 
6.1.19 Fast Protein Liquid Chromatography 
Fast protein liquid chromatography (FPLC) was performed using either a Bio-Rad 
Biologic Protein Chromatography system or an ÄKTApurifierTM (GE Healthcare), 
at 4 °C or room temperature to purify all proteins. All solvents and buffers were 
filtered using a 0.2 µm filter (Millipore) prior to use. Protein samples were also 
filtered (0.2 µm) before loading to a 10 mL or 50 mL Superloop
TM
 (GE 




6.1.20 Hydrophobic Interaction Chromatography 
For HIC the protein sample was slowly combined with (NH4)2SO4 (1 M), 
immediately prior to being loaded onto a Source
TM
 15Phe® (GE Healthcare) 
column, pre-equilibrated with high salt buffer (10 mM BTP, 1 mM EDTA, 1 M 
(NH4)2SO4, pH 7.3).  The HIC procedure was performed at room temperature 
following a step-wise method, where the protein was eluted from the column with 
low salt buffer (10 mM BTP, 1 mM EDTA, pH 7.3), as the concentration of 
(NH4)2SO4 was lowered from 1 M to 0 M. Fractions exhibiting UV absorbance at 
280 nm were analysed by SDS-PAGE and those containing the protein of interest 
pooled and concentrated, using a 20 mL 10 kDa molecular weight cut-off 
(MWCO) device (Sartorius Stedim Biotech).  
 
6.1.21 Size-Exclusion Chromatography 
SEC was performed using either a Superdex S200 26/60 (GE Healthcare) or 
Superdex S200 HR 10/300 column (GE Healthcare) pre-equilibrated with buffer 
(10 mM BTP, 100 mM KCl, 200 µM PEP, 1 mM EDTA, pH 7.3). SEC was 
conducted at 4 °C and protein eluted from the column dependent on biomolecule 
size. Fractions exhibiting UV absorbance at 280 nm were analysed by SDS-PAGE 
and those containing the protein of interest pooled and concentrated, using a 20 
mL 10 kDa MWCO device.  
 
6.1.22 Polyacrylamide Gel Electrophoresis 
SDS-PAGE was performed using a Bolt® 10% Bis-Tris Plus precast protein gel 
(Invitrogen) run in a Mini Gel Tank (Invitrogen). Samples were boiled prior to 
loading of gel wells and a Novex® Sharp pre-stained protein standard (Invitrogen) 
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run as a molecular weight marker. Gels were run in MOPS buffer at 200 V, for 32 
minutes. For protein visualisation gels were stained with Coomassie Brilliant Blue 
R250 in 50% (v/v) methanol, 10% (v/v) acetic acid for approximately 30 minutes, 
followed by de-staining in 40% (v/v) methanol and 10% (v/v) acetic acid for 30 
minutes. Images were captured using a Molecular Imager® Gel DocTM XR, 
visualised under UV (302 nm).  
 
6.1.23 Protein Concentration and Buffer Exchange 
For protein concentration during and after purification, a 20 mL 10 kDa MWCO 
device was utilised, which had been washed with 2-3 volumes of Milli-Q. Proteins 
were buffer exchanged via dilution with the desired buffer and repeatedly 
concentrated by centrifugation (4000 g, 4 °C).   
 
6.1.24 Protein Concentration Determination 
Protein concentration was determined by measuring the UV absorbance at 280 nm 
for a 2 µL sample, with a Nanodrop ND-1000 spectrophotometer (Thermo 
Scientific). The protein extinction coefficient was calculated using the ExPASY 
ProtParam tool (http://web.expasy.org/protparam/).  
 
6.1.25 Protein Storage 
Purified protein was separated into 50 µL, 100µL or 200 µL aliquots; snap frozen 





6.1.26 Molecular Weight Determination 
Protein molecular weight was measured by electrospray ionisation mass 
spectrometry using a Bruker maXis
TM
 3G (Bruker Daltonics). Protein samples 
were buffer exchanged into Milli-Q and diluted to a concentration of 1 mg/mL for 
analysis.   
 
6.1.27 Enzyme Kinetics Assay 
DAH7PS activity was assessed using a continuous spectrophotometric assay, 







) using a Varian Cary 100 UV Visible Spectrophotometer. 
Measurements were made in triplicate using a quartz cuvette, with a 1 cm path 
length. Standard reaction mixtures contained PEP (200 µM), E4P (300 µM) and 
MnSO4 (100 µM) in BTP buffer (50 mM BTP, pH 7.3), with enzyme (2 mg/mL) 
to a total volume of 1 mL. BTP buffer was made up in Chelexed Milli-Q, which 
was then used to prepare PEP and E4P solutions. MnSO4 and Tyr solutions were 
made up in Chelexed Milli-Q. The reaction mixture comprising PEP, MnSO4 and 
BTP buffer was incubated for 7 minutes at 60 °C prior to the addition of enzyme. 
The reaction mixture was then incubated for an additional 2 minutes before the 
assay was initiated by the addition of E4P. Initial rates of reaction were 
determined by least squares fitting to the initial rate data. Km and kcat values were 
determined by fitting the initial rates to the Michaelis-Menten equation using 
Grafit software (Erithacus).  
 
6.1.28 Substrate Concentration Determination 
A standard assay was performed in triplicate to determine the concentration of 
PEP and E4P stock solutions. To assess the concentration of either substrate, a 
reaction mixture containing one substrate in excess, with the other limiting, 
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MnSO4 (100 µM) and enzyme in BTP buffer; was initiated by the addition of E4P. 
Upon completion of the reaction the change in absorbance was measured and the 
Beer-Lambert Law applied to determine the concentration of either PEP or E4P 












at 60 °C, l 
= 1 cm).  
 
6.1.29 Feedback Inhibition Studies 
Tyr and Phe stock solutions (20 mM) were made up in Chelexed Milli-Q and 
added to standard assay reaction mixtures to give a total reaction volume of 1 mL.  
 
6.2 Chapter Two Methods 
 
6.2.1 PCR Amplification of 
WT
TmaDAH7PS  
Before commencing this research, the gene for TmaDAH7PS (locus tag TM0343) 
had been amplified from purified T. maritima MSB8 (DSM 3109) genomic DNA, 
using primers designed to introduce NdeI and BglII recognition sites. The 1036 bp 
PCR product was ligated into the pT7-7 vector, digested with NdeI and BamHI.
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The pT7-7 vector was transferred into E. coli XL1-Blue cells and the resulting 
construct transformed into E. coli BL21*(DE3) cell lines for protein expression. 
Sequencing analysis confirmed the presence of the 
WT
TmaDAH7PS sequence, 
within the expression plasmid.   
 
6.2.2 Site-directed Mutagenesis 







were constructed by site-directed mutagenesis using a Quik-Change® Lightning 
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Site-Directed Mutagenesis Kit (Stratagene). 
V65P
TmaDAH7PS was constructed 
prior to the beginning of this research however the same protocol was followed to 
generate the R64P and P68A TmaDAH7PS linker mutations. The pT7-7 
TmaDAH7PS plasmid was used as a double stranded template and the amino acid 
substitutions (R64P or P68A) introduced using synthetic oligonucleotide primers, 
harbouring the desired mutations; complementary to each strand of the pT7-7 
TmaDAH7PS plasmid. The forward and reverse primers for the R64P and P68A 
TmaDAH7PS linker mutations are shown below, with codons representing the 










The Quik-Change® Lightning Site-Directed Mutagenesis procedure involved 
extension of mutagenic primers by Phusion® High Fidelity DNA polymerase 
during temperature cycling, to generate a nicked mutant plasmid. The PCR 
product was treated with DpnI to digest parental DNA, before transformation into 
Stellar
TM
 competent cells. Transformants were grown overnight at 37 °C and the 
plasmids extracted using a Nucleospin® Plasmid Easy Pure Kit for DNA 
sequencing. Upon sequence confirmation, constructs were transformed into E. coli 





6.2.3 Kinetic Characterisation 

















E4P concentration was fixed at 300 





PEP concentration was fixed at 200 µM, while E4P 
concentration was varied from 20 µM to 300 µM.  
 
6.2.4 Enzyme Activity in Presence of Inhibitors 
The standard enzyme kinetics assay was employed to determine enzyme activity 









TmaDAH7PS. PEP concentration was fixed at 200 μM 
and E4P concentration at 300 μM, while the concentration of Tyr or Phe was 
varied from 0 µM to 400 μM. Initial rates for each ligand concentration were 
compared to those of standard assay conditions to determine the loss of activity. 
Assays were performed in triplicate.  
 
6.2.5 Differential Scanning Fluorimetry 
DSF was employed to measure protein melt temperatures using an iCycler iQ5 
Multicolour Real-Time PCR Detection System (Bio-Rad). Protein samples (1 
mg/mL) with buffer (50 mM BTP, pH 7.3), 20x SYPRO® Orange dye and 1 mM 
Tyr (where necessary) were aliquoted as 25 µL triplicates, into a 96-well plate. A 
blank was prepared for each sample, by substituting protein for buffer. The melt 
proceeded in 0.2 °C increments from 20 °C to 95 °C, with a dwell time of 20 
seconds after each temperature rise. Fluorescence was measured at the end of each 
dwell time.   
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6.2.6 Differential Scanning Fluorimetry Data Analysis 
DSF data analysis was performed using an Excel spreadsheet with a custom VBA-
scripted macro to toggle and dynamically display melt and derivative curves, for 
each protein sample. Melt temperatures were calculated as the temperature of 
maximum inflection of the melting curve, after subtracting absorbance of the 
sample blank. Error bars associated with DSF plots represent the standard 
deviation between triplicate measurements.   
 
6.2.7 Small Angle X-ray Scattering Data Collection 
SAXS data was collected at the Australian Synchrotron SAXS/WAXS beamline 
equipped with a Pilatus detector. The wavelength of the X-rays was 1.0332 Å and 
the sample detector distance set at 1600 mm. Scattering data was collected from 
enzymes (10 mg/mL) following elution from a SEC column (Superdex 200 5/150) 
pre-equilibrated with buffer (10 mM BTP, 100 mM KCl, 200 µM PEP, pH 7.3) 
with or without Tyr (1 mM). Two-dimensional intensity plots from the peak of the 
size-exclusion chromatography run were radially averaged, normalised to sample 
transmission and the background subtracted.   
 
6.2.8 Small Angle X-ray Scattering Data Analysis 
The scatterbrain software (Australian Synchrotron) was utilised to process all 
primary SAXS data collected. Guinier fits were plotted using PRIMUS.
85
 Indirect 
Fourier transformation was performed using GNOM to generate the P(r) function, 
providing both the relative probability of distances between scattering centres and 
the maximum dimension of scattering (Dmax). Theoretical scattering curves were 
generated from atomic coordinates (PDB 1RZM and 3PG9) using CRYSOL.
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6.3 Chapter Three Methods 
 
6.3.1 Open and Closed System Preparation 
TmaDAH7PS crystal structures capturing both the open form co-crystallised with 
PEP and E4P (PDB: 1RZM) and the closed form co-crystallised with Tyr (PDB: 
3PG9) were used as starting points for the MD simulations. Tetrameric structures 
were generated from the associated dimer in the asymmetric unit, based on 
crystallographic symmetry. Preparation of the open form involved the removal of 
PEP and E4P molecules to enable protein dynamics to be assessed in the absence 




ions was performed 
using COOT
111
 and parameters for Mn
2+ 
added to the CHARMM all atom 
parameter set 22.
88
 The protonation state for ionisable residues was calculated 
using MCCE
112
 for histidine and PROPKA
113
 for all other residues, with the 
results averaged per protein chain. The open system was solvated in a TIP3 water 
box of dimensions 109 Å X 97.2 Å X 98.9 Å, while the closed system had 
dimensions 99.1 Å X 102 Å X 101 Å. The net charge of the system was 




 ions, which were added with a 
minimum 5 Å distance between individual ions and between the enzyme and each 
ion.  
 
6.3.2 Molecular Dynamics Simulations 
NAMD
88
 was utilised to carry out all MD simulations, using the CHARMM all 
atom parameter set 22. MD simulations were run using 1024 cores of the IBM 
Blue Gene/P computer from the high performance supercomputing and services 
facility, at the University of Canterbury. Electrostatic interactions were calculated 
using the PME method, with a Van der Waals cut-off of 12 Å. Each MD 
simulation was performed at 1 atmosphere and 363 K, the known optimal 
temperature for T. maritima activity. For each simulation an energy minimisation 
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of 5000 steps, using the conjugate gradient energy minimisation method was run. 
Time steps of 2 fs were utilised and a trajectory written out every 100 ps.  
 
6.3.3 Targeted Molecular Dynamics Simulations 
TMD simulations were run using the open and closed systems as either the initial 
starting, or final target structure, depending on the direction of the simulation. 
TMD simulations were run for the open to closed form and closed to open form, 
by applying a force constant of 600 kcal/mol/Å
2
 to the alpha carbon of residues 1 
to 80 of TmaDAH7PS. TMD simulations were run over 5,000,000 steps, with the 
relevant open or closed crystal structure used as the final target, with a RMSD of 
0.2 Å set for the final TMD step.  
 
6.3.4 Trajectory Analysis 
All simulations were prepared, displayed and analysed using the molecular 
visualisation program VMD.
114
 For both the open and closed conformation of 
TmaDAH7PS Val65 was mutated to Pro (V65P) in silico, using mutator plug-in 
(version 1.3). Trajectories were aligned in VMD with respect to the TIM barrel of 




6.4 Chapter Five Methods 
 
6.4.1 Crystallisation Trials 
Manual screening for crystallisation conditions, via hanging-drop vapour 
diffusion in 24 well plates, was performed using 1 µL drops of protein and 500 µL 
of appropriate well solution. 
V65P
TmaDAH7PS concentrations tested included 4 
107 
 
mg/mL, 6 mg/mL and 10 mg/mL. Crystal trays were prepared at room 
temperature before storage at 20 °C. Crystal trays and pipette tips were flushed 
with nitrogen prior to use.     
 
6.4.2 Isothermal Titration Calorimetry 




TmaDAH7PS. ITC experiments were performed using a low volume Nano 




TmaDAH7PS samples were 
extensively dialysed into buffer (50 mM BTP, pH 7.3), which was also used to 
prepare Tyr solutions. Protein and Tyr solutions were degassed under vacuum for 
10 minutes prior to use. The sample cell was loaded with 300 µL of protein 
sample (27-284 µM) and the syringe filled with 50 µL of Tyr solution (0.3-3 
mM). 2 µL Tyr injections were performed at 240 second intervals. The heat of 
dilution was determined by injecting Tyr into buffer and subtracted from the 
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